13_cis_retinoic_acid
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   10.6160    5.4820   -0.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9350    3.3080   -0.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1650   -3.7930   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360   -5.2870   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -6.0950   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270   -3.2930    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2930   -5.6270    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720   -4.1470    0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -3.1060    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2620   -3.5100   -1.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   -1.8530    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5940   -3.7230    1.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -1.0700    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5800    0.3580    0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    1.0310    0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7270    1.0260    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    2.4440    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0420    3.0690    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2550    4.4870    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0830    5.3300    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4270    5.0940    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7040    4.4870   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
13_cis_retinoic_acid

> <PRIMARY_SOM>
7

>  <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

$$$$
1_1-dichloro-2_2_2-trifluoroethane
  MOE2008           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.1610    0.3970   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3500   -0.9880    0.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040   -1.0260    0.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0580   -1.3940    1.5050 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730   -1.9080   -0.6150 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9390    0.4550   -0.1350 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4430    1.6380    1.0540 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
M  END
>  <ID>
1_1-dichloro-2_2_2-trifluoroethane

> <PRIMARY_SOM>
1

>  <Citation>
G. Urban et al., Chem. Res. Toxicol., 1994, 7, 170-176

$$$$
1_2-dibromoethane
  MOE2008           3D

  4  3  0  0  0  0  0  0  0  0999 V2000
   -0.4080   -0.0260    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -0.1780    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -0.3030    1.8020 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020   -1.8040    0.3000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
M  END
>  <ID>
1_2-dibromoethane

> <PRIMARY_SOM>
1 2 3 4

>  <Citation>
Wormhoudt et al., Chemico-Biological Interactions, 1996, 101,175-192

>  <DOI>
10.1016/0009-2797(96)03723-4

$$$$
1_2_4_trichlorobenzene
  MOE2008           3D

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0020   -0.0040    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0220    1.7320    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    2.4400    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.8220    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0570    4.4980    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2480    3.7900    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2290    2.4070    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0800    6.2340    0.0380 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    4.6380    0.0550 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  1  0  0  0  0
M  END
>  <ID>
1_2_4_trichlorobenzene

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
4

>  <Citation>
Bogaards, J.J.P.; Omen, B.V.; Wolf, C.R.; Van Bladeren, P.J. Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes. Toxicol. Appl. Pharamcol. 1995, 132, 44–52.

$$$$
2-acetylbenzothiophene
  MOE2008           3D

 12 13  0  0  0  0  0  0  0  0999 V2000
    1.3680   -0.0260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -1.0630    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8970   -0.6570    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9960    0.7350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5590    1.4760    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -1.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3260   -0.7760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980    0.6090   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410    1.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -0.1330    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4080   -1.2100    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6040    1.1440    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
M  END
>  <ID>
2-acetylbenzothiophene

> <PRIMARY_SOM>
5

>  <Citation>
Elizabeth M. Joshi, Brian H. Heasley, Mahendra D. Chordia, and Timothy L. Macdonald, In Vitro Metabolism of 2-Acetylbenzothiophene:  Relevance to Zileuton Hepatotoxicity, Chem. Res. Toxicol., 2004, 17 (2), pp 137–143

>  <DOI>
10.1021/tx0341409

$$$$
2n_propylquinoline
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4130    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2400   -0.6710   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    0.0490   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    1.4430   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1940    2.1230    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    2.0780    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480   -0.6850    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3940    1.3220    0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3050   -0.0680    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -0.8850    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5640   -1.8500   -1.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8500   -2.6800   -1.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  9  2  0  0  0  0
  8 10  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
2n_propylquinoline

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
3 4 5 6

>  <Citation>
Belliard et al.,Xenobiotica,33,341,2003

$$$$
3-cyano-7-ethoxycoumarin
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5570    1.5720   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 15  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 15 16  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

$$$$
3-cyano-7-methoxycoumarin
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 14 15  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-methoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

>  <DOI>
10.1124/dmd.30.7.845

$$$$
3-ethoxy-4-trifluoromethylcoumarin
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4650   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5450    1.5830   -0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4170    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4690   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 18  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
3-ethoxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
E. L. Code, C. L. Crespi, B. W. Penman, F. J. Gonzalez, T. K. H. Chang, D. J. Waxman, Drug Metab. Dispos. 1997, 25, 985-993.

$$$$
3-methoxy-4-trifluoromethylcoumarin
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 17  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <ID>
3-methoxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ghosal et al.,Biopharm. Drug Disp.,24,375,2003

>  <DOI>
10.1002/bdd.374

$$$$
3-methylindole
  MOE2008           2D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.8640    0.9810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490    0.3140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8640   -0.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350   -0.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
3-methylindole

> <PRIMARY_SOM>
2

>  <Citation>
Thornton-Manning, J.; Appleton, J.L.; Gonzalez, F.J.; Yost, G.S. Metabolism of 3-Methylindole by Vaccinia-Expressed P450 Enzymes: Correlation of 3-Methyleneindolenine Formation and Protein-, Binding. J. Pharmacol. Exp. Ther. 1999, 276, 21–29.

$$$$
4-chloromethyl-7-ethoxycoumarin
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3010    0.6480    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1110    1.3590   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.6630   -0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220    1.4250   -0.2790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3910    0.6150   -0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840    1.5260   -0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910   -0.7310   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100   -1.4280    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3230   -0.7430    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6060   -1.4210    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6680   -2.9040    0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5540   -3.6600   -1.2370 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7160   -0.6880    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7200    0.7750    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7670    1.4060    0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900    1.3980    0.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 16  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
4-chloromethyl-7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

$$$$
4-nitroanisole
  MOE2008           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -0.0580    3.4920   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9940    4.1700   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0320    3.4740    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.0870    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    1.3990   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910    0.0510   -0.6710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2200   -0.7200   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700    2.1080   -1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    5.6220    0.0430 N   0  3  0  0  0  0  0  0  0  0  0  0
   -1.7350    6.1850    0.7500 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    6.2020   -0.5330 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  2  0  0  0  0
  2  9  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  CHG  1   9   1
M  CHG  1  11  -1
M  END
>  <ID>
4-nitroanisole

> <PRIMARY_SOM>
7

>  <Citation>
B.C. Jones et al., Xenobiotica, 1997, 27, 1025-1037

$$$$
4-vinylcyclohexene
  MOE2008           3D

  8  8  0  0  1  0  0  0  0  0999 V2000
    1.1900    0.6800    0.1770 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.3970    1.2320    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    2.2210    1.7380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1060    1.3910    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3270    0.6470    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3030   -0.6240   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630   -1.4470   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1090   -0.8150    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  8  1  0  0  0  0
  2  3  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
4-vinylcyclohexene

> <PRIMARY_SOM>
2 3

> <SECONDARY_SOM>
5 6

>  <Citation>
Fontaine et al.,Drug Metab. Disp.,29,179,2001

$$$$
4_nitro_phenol
  MOE2008           2D

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0360    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1020   -0.5220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1020   -0.5220    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
    1.2300    2.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300    3.6160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    4.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    5.7020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    3.6160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2 10  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  2  0  0  0  0
  9 10  1  0  0  0  0
M  CHG  1   1   1
M  CHG  1   4  -1
M  END
>  <ID>
4_nitro_phenol

> <PRIMARY_SOM>
6 9

>  <Citation>
Tassaneeyakul et al., Biochem. Pharmacol., 1993, 46, 1975-1981

>  <DOI>
10.1016/0006-2952(93)90639-E

$$$$
5_methylchrysene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4100    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2540    2.1320    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2390    2.1040    0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2490   -0.6870   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1980   -0.6580    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    1.3940    0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    3.5210   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4180    1.4480   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4580    0.0500   -0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -1.9950   -0.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840    0.0030    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    2.0670    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5190    4.1500   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6880   -0.6120   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5320   -2.6010   -0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7000    3.4220   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7150   -1.9180   -0.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -2.1030    0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  6 19  1  0  0  0  0
  7 12  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 10  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  2  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
5_methylchrysene

> <PRIMARY_SOM>
18 15

> <SECONDARY_SOM>
19

> <TERTIARY_SOM>
17 13

>  <Citation>
Koehl et al.,Cancer Res.,56,316,1996

$$$$
6-nitrochrysene
  MOE2008           2D

 21 24  0  0  0  0  0  0  0  0999 V2000
    1.7860    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.6500    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.3570   -2.0620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -2.0620    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 18  1  0  0  0  0
  6  7  1  0  0  0  0
  6 15  2  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  8 19  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  2  0  0  0  0
 19 21  1  0  0  0  0
M  CHG  1  19   1
M  CHG  1  21  -1
M  END
>  <ID>
6-nitrochrysene

> <PRIMARY_SOM>
19

>  <Citation>
Chae, Y.H.; Yun, C.H.; Guengerich, F.P.; Kadlubar, F.F.; El-Bayoumy, K. Roles of Human Hepatic and Pulmonary Cytochrome P450 Enzymes in the Metabolism of the Environmental Carcinogen 6-Nitrochrysene. Cancer Res. 1993, 53, 2028–2034. 

$$$$
6_methylchrysene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0120    1.4320    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320    0.0250   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    2.1090    0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.1260   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2590   -0.6530   -0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -0.6670   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    1.3760    0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2790    3.5050    0.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4370    1.4680   -0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    0.0880   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3430   -2.0470   -0.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960   -0.0150    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6350   -0.8460    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6310    2.0590    0.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    4.1680    0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6800   -0.5540   -0.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5640   -2.6850   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6650    3.4420    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7330   -1.9370   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 12  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 10  1  0  0  0  0
 10 16  1  0  0  0  0
 11 17  2  0  0  0  0
 12 13  1  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  2  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
6_methylchrysene

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
16 18

>  <Citation>
Koehl et al.,Cancer Res.,56,316,1996

$$$$
7-ethoxycoumarin
  MOE2008           3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    1.3350    0.6350    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1530    1.3550   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500    0.6620   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    1.4310   -0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420    0.6270   -0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5300    1.5460   -0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -0.7360   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -1.4460   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410   -0.7550    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980   -1.4580    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7280   -0.7630    0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7030    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8120    1.3130    0.4350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    1.3580    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

$$$$
7-ethoxyresorufin
  MOE2008           2D

 18 20  0  0  0  0  0  0  0  0999 V2000
    5.5300    1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0600    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5300   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280    0.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7920    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
7-ethoxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Qwihee P. Lee, Alan G. Fantel and Mont R. Juchau Biochemical Pharmacology Volume 42, Issue 12, 27 November 1991, Pages 2377-2385 

>  <DOI>
10.1016/0006-2952(91)90244-Y

$$$$
7-methoxyresorufin
  MOE2008           2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    5.5300    1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0600    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5300   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280    0.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
7-methoxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Qwihee P. Lee, Alan G. Fantel and Mont R. Juchau Biochemical Pharmacology Volume 42, Issue 12, 27 November 1991, Pages 2377-2385 

>  <DOI>
10.1016/0006-2952(91)90244-Y

$$$$
9_anthraldehyde
  MOE2008           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4600   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770    2.1810    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2650    2.1200    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.6950   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180   -0.6990   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    1.5080   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4100    1.3890    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4390    0.0450   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -0.0040   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200    2.2180    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6860   -0.6010   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7940    1.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8280    0.1400   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -2.1100   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2290   -2.7390    0.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 15  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
M  END
>  <ID>
9_anthraldehyde

> <PRIMARY_SOM>
15

>  <Citation>
Watanabe et al.,Drug Metab. Pharmacokin.,17,516,2002

$$$$
CP_125_611
  MOE2008           3D

 26 28  0  0  1  0  0  0  0  0999 V2000
    0.8370    0.6700   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4420    1.2230   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500    1.1140   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6340    1.6900   -0.0550 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7660    0.4380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5120   -0.1160    1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3130    0.0020   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7090    3.2000   -0.3090 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.0000    4.0160    0.6700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6120    4.1550    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1560    5.0480    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430    3.6880   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0570    2.8440   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8980    1.3690   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.9120   -0.9120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    4.5450    2.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    3.1990    2.3250 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    5.3950    3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5700    6.7730    2.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380    7.2990    1.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    8.6620    1.8000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1970    9.1930    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720    8.8030    1.0190 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960    8.8320   -0.4300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570   10.5420    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0390    6.4310    1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 16  1  0  0  0  0
 11 26  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 20 26  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 22 24  1  0  0  0  0
 22 25  1  0  0  0  0
M  END
>  <ID>
CP_125_611

> <PRIMARY_SOM>
8

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
CP_677_623
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.8080    3.8640    0.5460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930    4.1910    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2830    5.0800    0.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2670    4.5630    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    3.2130    1.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910    2.8110    2.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9700    5.4250    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    6.7920    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250    7.3130    1.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5390    8.6650    1.8480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4560    9.2040    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6730    8.6930    1.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560    8.9780   -0.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5090   10.5410    1.1800 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    6.4530    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 15  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
M  END
>  <ID>
CP_677_623

> <PRIMARY_SOM>
6

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
DDTC_Me
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DDTC_Me

> <PRIMARY_SOM>
6 7

>  <Citation>
Madan et al.,Alcohol. Clin. Exp. Res.,22,1212,1998

>  <DOI>
10.111/j.1530-0277.1998.tb03901.x

$$$$
DETC_Me
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DETC_Me

> <PRIMARY_SOM>
8

>  <Citation>
Madan et al.,Drug Metab. Disp.,23,1153,1995

$$$$
DMBA
  MOE2008           2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  6 20  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 13 19  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
DMBA

> <PRIMARY_SOM>
8 9

> <SECONDARY_SOM>
19 20

> <TERTIARY_SOM>
3 4 15 17

>  <Citation>
Shou, M.; Korzekwa, K.R.; Krausz, K.W.; Buters, J.T.; Grogan, J.; Goldfarb, I.; Ardwick, J.P.H.; Gonzalez, F.J.; Gelboin, H.V. Specificity of cDNA-Expressed Human and Rodent Cytochrome P450s in the Oxidative Metabolism of the Potent Carcinogen 7,12-Dimethylbenz[a]anthracene. Mol. Carcinog. 1996, 17, 241–249. 

>  <DOI>
10.1002/(SICI)1098-2744(199612)17:4<241::AID-MC8>3.0.CO;2-G

$$$$
ETBE
  MOE2008           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.2390    3.0960    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560    2.3780    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2360    3.1010   -0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    2.3860    0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710    1.0400    0.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0890    1.0380    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5990   -0.3640    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
ETBE

> <PRIMARY_SOM>
6

>  <Citation>
J-Y. Hong et al., Arch. Toxicol., 1997, 71, 266-269

$$$$
FLU-1
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.1410    1.5410   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6190    1.7140   -0.4590 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.1160    0.0520   -0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.3140   -0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3570    4.2450    0.2480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    2.2130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    3.7010   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3580    2.1900   -1.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9030    0.7820    0.3010 O   0  5  0  0  0  0  0  0  0  0  0  0
   -1.1220    3.6010    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -0.4180   -0.8400 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720   -0.3770   -1.4370 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.4400   -0.6190    0.6650 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    4.3410    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  1  6  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  2  0  0  0  0
  2  9  1  0  0  0  0
  3 11  1  0  0  0  0
  3 12  1  0  0  0  0
  3 13  1  0  0  0  0
  4  7  1  0  0  0  0
  5 10  1  0  0  0  0
  6 10  2  0  0  0  0
  7 14  2  0  0  0  0
 10 14  1  0  0  0  0
M  CHG  1   2   1
M  CHG  1   9  -1
M  END
>  <ID>
FLU-1

> <PRIMARY_SOM>
14

>  <Citation>
Goda et al.,Drug Metab. Disp.,34,828,2006

>  <DOI>
10.1124/dmd.105.008623

$$$$
GTS-21
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.3480    0.4550    2.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2390   -0.9250   -0.3110 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280    1.8680    0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5370   -2.8250    0.2630 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5010    2.1630    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2930    3.2700   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0930    0.8430    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7250    3.1610    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810    0.8150   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3490   -0.2160   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2690   -0.4780   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1010   -0.3620   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9310   -0.0350    0.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6760   -0.9230   -1.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3790   -0.5250   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000   -1.6410    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3130   -0.2400    0.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0520   -1.1250   -1.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8790   -0.7750   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0610   -1.7220   -1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6010   -2.8340   -0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3120    0.7330    3.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7060   -1.4870   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  1 22  1  0  0  0  0
  2 19  1  0  0  0  0
  2 23  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 16  2  0  0  0  0
  4 21  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  2  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 15  2  0  0  0  0
 11 16  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 13 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 20  1  0  0  0  0
 17 19  2  0  0  0  0
 18 19  1  0  0  0  0
 20 21  2  0  0  0  0
M  END
>  <ID>
GTS-21

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
22

>  <Citation>
R. Azuma, M. Komuro, B. H. Korsch, J. C. Andre, O. Onnagawa, S. R. Black, J. M. Mathews, Xenobiotica 1999, 29, 747-762.

>  <DOI>
10.1080/004982599238362 

$$$$
Genistein
  MOE2008           2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.3570    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2150    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2150   -1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  1  0  0  0  0
  2 12  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  6  7  2  0  0  0  0
  6 19  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 18  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 20  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
Genistein

> <PRIMARY_SOM>
14 16

>  <Citation>
Roberts-Kirchhoff, E.S.; Crowley, J.R.; Hollenberg, P.F.; Kim, H. Metabolism of Genistein by Rat and Human Cytochrome P450s. Chem. Res. Toxicol. 1999, 12, 610–616.

>  <DOI>
10.1021/tx9802320

$$$$
KR_31543
  MOE2008           3D

 33 36  0  0  1  0  0  0  0  0999 V2000
    1.0150    1.1300   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220    1.7620    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    1.0890    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5460    1.7390    0.8530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1570   -0.2340    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0750   -0.8700    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590   -0.1840    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390   -0.8740    0.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5270   -0.0540    0.2840 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.6600   -1.0050   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8100    0.6000    1.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9170   -0.4100    2.6570 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3930    0.1030    3.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9870    1.3930    1.6100 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750    2.4350    2.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3710    0.9490   -0.8510 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.5380    1.7130   -1.0970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1730    1.8490   -0.6210 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8230    2.6560   -1.7830 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.4620    2.1370   -3.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8320    4.1040   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.7500   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    0.7570   -3.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0320    0.2260   -4.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190    1.0870   -5.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2660    0.4480   -7.0470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7700    2.4620   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1380    2.9710   -4.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.5820    0.6260 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8540    5.2830    1.0850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4040    5.8260   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5740    6.6630    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8060    5.5510   -1.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 18  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 16  1  0  0  0  0
 11 12  1  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 23  1  0  0  0  0
 20 28  2  0  0  0  0
 21 22  1  0  0  0  0
 22 29  1  0  0  0  0
 22 33  2  0  0  0  0
 23 24  2  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  2  0  0  0  0
 27 28  1  0  0  0  0
 29 30  2  0  0  0  0
 30 31  1  0  0  0  0
 31 32  1  0  0  0  0
 31 33  1  0  0  0  0
M  END
>  <ID>
KR_31543

> <PRIMARY_SOM>
18

>  <Citation>
Ji et al,Arch. Pharm. Res.,27,239,2004

$$$$
MEXILETINE
  MOE2008           3D

 13 13  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -0.7760    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    3.5980    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5560    2.2420    1.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8890    2.9890    1.4710 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.7930    4.2920    0.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9560    2.1500    0.9100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  7 10  1  0  0  0  0
  9 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
MEXILETINE

> <PRIMARY_SOM>
13

>  <Citation>
L. LABBE, Z. ABOLFATHI, E . LESSARD, H. PAKDEL, P. BEAUNE and J. TURGEON, xenobiotica, 2003, vol. 33, no. 1, 13-25 

>  <DOI>
10.1080/0049825021000017948

$$$$
MOP-13031
  MOE2008           3D
MOP-13031
 24 25  0  0  1  0  0  0  0  0999 V2000
   -0.1940    1.6540    0.1420 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.3410    0.1490    0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9370    2.1420    1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5070    2.3630    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7030   -0.5270    1.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1100   -0.5820   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910    2.9770    2.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2770    1.6930    0.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510    3.1750    1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6130    2.1490   -0.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8260   -1.9150    1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2370   -1.9710   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5870    3.4620    2.3120 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420    3.5180    2.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790    1.4610    1.6910 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5950    1.4850   -0.5310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9230    3.8790    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1030    1.9980   -1.7940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960    2.1220   -0.2460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5970   -2.6460    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -2.6130    2.5410 N   0  3  0  0  0  0  0  0  0  0  0  0
   -3.1330    1.7920   -2.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3610   -1.9350    3.5650 O   0  5  0  0  0  0  0  0  0  0  0  0
   -1.3300   -3.8430    2.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  2  0  0  0  0
 11 21  1  0  0  0  0
 12 20  1  0  0  0  0
 18 22  1  0  0  0  0
 21 23  1  0  0  0  0
 21 24  2  0  0  0  0
M  CHG  1  21   1
M  CHG  1  23  -1
M  END
>  <ID>
MOP-13031

> <PRIMARY_SOM>
13 1

>  <Citation>
Kudo et al.,Drug Metab. Disp.,27,303,1999

$$$$
MTBE
  MOE2008           3D

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.2390    3.0960    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560    2.3780    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2360    3.1010   -0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    2.3860    0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710    1.0400    0.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    1.0380    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
MTBE

> <PRIMARY_SOM>
6

>  <Citation>
J-Y. Hong et al., Arch. Toxicol., 1997, 71, 266-269

$$$$
NDBA
  MOE2008           3D

 11 10  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7490    4.0150   -1.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690    3.8390   -2.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4100    4.8020   -0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8540    4.9110   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
NDBA

> <PRIMARY_SOM>
4 5

>  <Citation>
Hirotaka Kushida et al., Carcinogenesis, 21, 1227-1232, 2000

$$$$
NDEA
  MOE2008           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
   -1.4200    2.1290    0.5220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.7790    1.2100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3770    3.4350    0.4020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0280    3.8820    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090    3.6260   -1.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2950    3.9590   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7110    4.0650   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
NDEA

> <PRIMARY_SOM>
4 6

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NDMA
  MOE2008           3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -1.3690    2.2250    0.6680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
M  END
>  <ID>
NDMA

> <PRIMARY_SOM>
4 5

>  <Citation>
Hirotaka Kushida et al., Carcinogenesis, 21, 1227-1232, 2000

$$$$
NDPA
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8900    4.0580   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4940    4.8650   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
NDPA

> <PRIMARY_SOM>
4 5

>  <Citation>
Teiber et al., Carcinogenesis, 2000, 21, 1559-1566

$$$$
NMBA
  MOE2008           3D

  8  7  0  0  1  0  0  0  0  0999 V2000
   -1.4650    2.1740    0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6120    1.8440    1.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3880    3.4570    0.4440 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0270    3.8870    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    3.9110   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4850    3.5250   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    4.0240   -1.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4100    3.6640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
NMBA

> <PRIMARY_SOM>
5

> <SECONDARY_SOM>
4

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NMEA
  MOE2008           3D

  6  5  0  0  1  0  0  0  0  0999 V2000
   -1.3300    2.1530    0.6200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160    1.6620    0.9520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    3.4330    0.3750 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.3870    3.7480   -0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1580    4.0560    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000    3.7680   -1.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
NMEA

> <PRIMARY_SOM>
5

> <SECONDARY_SOM>
4

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NNK
  MOE2008           3D

 15 15  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6570   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0310   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.3520   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030    2.0870    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.1250    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2980    3.3380    0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960    1.3670    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7630    2.3580    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0850    1.5880    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2020    2.5370    0.0450 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    3.0880    1.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7620    2.8860   -1.0630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6900    3.6740   -1.0540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
M  END
>  <ID>
NNK

> <PRIMARY_SOM>
11

> <SECONDARY_SOM>
13

> <TERTIARY_SOM>
3

>  <Citation>
Smith et al.,Canc. Res.,52,1757,1992
Staretz et al.,Drug Metab. Disp.,25,154,1997

$$$$
NN_dimethyl_M_toluamide
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.1290    1.5810    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    1.2190    2.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1550    0.6120    2.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1900    0.3630    2.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.7200    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180    1.3260    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690    2.2250    0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    4.8880    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2880    4.8280    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940    0.2200    4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
NN_dimethyl_M_toluamide

> <PRIMARY_SOM>
14

>  <Citation>
Usmani et al.,Drug Metab. Disp.,30,289,2002

>  <DOI>
10.1124/dmd.30.3.289

$$$$
NPYR
  MOE2008           3D

  7  7  0  0  0  0  0  0  0  0999 V2000
   -1.5910    2.3840    0.9940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    1.6010    0.3230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000    3.4020    0.2730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2920    4.2830    1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0360    5.6000    1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920    5.6230   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200    4.2480   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
NPYR

> <PRIMARY_SOM>
4 7

>  <Citation>
Teiber et al., Carcinogenesis, 2000, 21, 1559-1566

$$$$
N_nitrosodiamylamine
  MOE2008           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.6270    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430    2.0350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950    2.2890    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7460    2.2580   -1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0100    3.0720    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0810    3.0050   -1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620    3.3250    2.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5330    3.2620   -2.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7760    4.1080    2.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8680    4.0080   -2.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
N_nitrosodiamylamine

> <PRIMARY_SOM>
10 11

> <SECONDARY_SOM>
8 9

> <TERTIARY_SOM>
6 7 12 13

>  <Citation>
Bellec et al.,Mutation Res.,377,199,1997

>  <DOI>
10.1016/S0027-5107(97)00073-0

$$$$
N_nitrosonornicotine
  MOE2008           3D

 13 14  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4260    2.0470   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    1.9870    1.2420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2070   -0.7020   -1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2350   -0.7070    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3420    3.2740    0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3230    2.7810    2.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1790   -2.0880   -1.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560   -2.0260    1.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0550   -2.7230    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770    1.7570    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3030    2.2110    2.6440 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  4 12  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7  8  1  0  0  0  0
  9 11  2  0  0  0  0
 10 11  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <ID>
N_nitrosonornicotine

> <PRIMARY_SOM>
8

>  <Citation>
Patten et al.,Carcinogenesis,18,1623,1997

$$$$
TAME
  MOE2008           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.6920    1.8740    2.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.1560    1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6890    1.8790   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2020    3.3260   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000    1.1630   -1.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    1.8810   -0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    2.5440    1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
TAME

> <PRIMARY_SOM>
7

>  <Citation>
J-Y. Hong et al., Arch. Toxicol., 1997, 71, 266-269

$$$$
abt_438
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6790   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0280   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4110   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0860    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1140    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7640    2.3510    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    1.3160    2.5010 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7490    2.3520    3.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9870    3.4140    3.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4880    3.4050    2.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3720    2.1320    5.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8830    1.9520    6.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5240    1.7260    7.5730 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.2220    2.9060    8.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0010    0.4930    8.1660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7400   -0.1900    9.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8410    0.2180    9.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2600   -1.3240    9.6090 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 13 14  3  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
abt_438

> <PRIMARY_SOM>
7

>  <Citation>
Machinist et al.,Drug Metab. Disp.,26,970,1998

$$$$
abt_761
  MOE2008           3D

 21 22  0  0  1  0  0  0  0  0999 V2000
   -0.1040    1.2970    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0510   -0.0830    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3070   -0.6640    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4110    0.1350   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2590    1.5130   -0.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0030    2.0930   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4520    1.9200    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7600    2.3130    1.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7580    1.3120    2.5780 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430    2.3780    3.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8700    3.4740    3.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3660    3.4390    2.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2780    2.1490    5.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8090    1.9580    6.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600    1.7290    7.5130 C   0  0  3  0  0  0  0  0  0  0  0  0
   -4.3350    2.9420    8.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0200    0.5360    8.2000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6670    0.2090    8.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.2210    9.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0050    0.0430    9.2060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1960   -1.3040    9.5950 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 13 14  3  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
 19 20  2  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
abt_761

> <PRIMARY_SOM>
7

>  <Citation>
Machinist et al.,Drug Metab. Disp.,26,970,1998

$$$$
acetaldehyde
  MOE2008           3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0140   -0.8670    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4740   -1.5050   -0.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3210   -1.9620   -1.7760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  2  0  0  0  0
M  END
>  <ID>
acetaldehyde

> <PRIMARY_SOM>
2

>  <Citation>
Bell-Parikh and Guengerich, J. Biol. Chem., 1999, 274, 23833-23840

>  <DOI>
10.1074/jbc.274.34.23833

$$$$
acetaminophen
  MOE2008           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    2.4050   -3.6550   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2420    2.2160   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9270    1.8530   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460    0.4550   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5710   -0.1110   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9720   -0.3690   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180   -1.4950   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8280   -1.7540   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510   -2.3000   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0810    2.6090   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7400    4.0660   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
acetaminophen

> <PRIMARY_SOM>
1 3

> <SECONDARY_SOM>
7 8

>  <Citation>
Chen et al.,Chem. Res. Toxicol.,11,295,1998

>  <DOI>
10.1021/tx9701687

$$$$
acrylonitrile
  MOE2008           3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.1620    0.1040   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8270   -1.0310   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1390   -2.2080   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5400   -3.3820   -0.2470 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  2  3  1  0  0  0  0
  3  4  3  0  0  0  0
M  END
>  <ID>
acrylonitrile

> <PRIMARY_SOM>
1 2

>  <Citation>
Kedderis et al., Chem. Res. Toxicol., 1993, 6, 866-871

$$$$
aminopyrine
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
    1.2340    0.6640   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    1.3640    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1000    0.6680    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.7260    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0540   -1.4490    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -2.8580    0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.7300   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -3.6770    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410   -3.3550    0.6360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -5.1190    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -6.2220    0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -6.1260    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350   -7.5700    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -5.0000   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -3.6910   -0.1960 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.4120   -3.2500   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 15  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 14  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
aminopyrine

> <PRIMARY_SOM>
12 13

>  <Citation>
Niwa et al.,Xenobiotica,29,187,1999

>  <DOI>
10.1080/004982599238731

$$$$
aniline
  MOE2008           2D

  7  7  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    1.4090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
aniline

> <PRIMARY_SOM>
5

>  <Citation>
H. Yamazaki et al., Biochemical Pharmacology, 1996, 52, 301

$$$$
antipyrine
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.5220    2.9500    0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2640    0.5920   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   -0.4150   -0.1310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4770    0.1550    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    0.4060    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.8060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900    1.4870    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9690   -1.7690   -0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370   -0.6370    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9960    1.4380   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7270   -0.7690    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3860    1.2840   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1170   -0.9260    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470    0.0990    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  4  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6  7  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
antipyrine

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
7

> <TERTIARY_SOM>
9

>  <Citation>
Sharer et al.,Drug Metab. Disp.,24,487,1996

$$$$
arachidonic_acid
  MOE2008           3D

 22 21  0  0  0  0  0  0  0  0999 V2000
   10.1270    3.3080   -2.6290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8510    4.8200   -0.9420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.5580    1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7460    0.7020    1.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    0.8720    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    1.4510    3.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    0.4310   -0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1120    0.5960    3.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4170    1.7080   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4690    0.6900    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050   -0.8280   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010   -1.9960   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6380    2.7370   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2360   -0.3180    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470   -2.3160   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2990   -2.6660   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2270   -1.6330    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4220   -2.2230   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6240   -2.7690   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5070   -3.3210    0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1780   -3.2830    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5920    3.7460   -1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 11  2  0  0  0  0
  9 10  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 12 16  1  0  0  0  0
 13 22  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 15 20  1  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 20 21  2  0  0  0  0
M  END
>  <ID>
arachidonic_acid

> <PRIMARY_SOM>
6

>  <Citation>
Rifkind et al.,Arch. Biochem. Biophys.,320,380,1995

>  <DOI>
10.1016/0003-9861(95)90023-3

$$$$
atomoxetine
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -0.1900    1.2080    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3720   -0.1630    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070   -1.0030    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9680   -0.4740    0.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    0.8970    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0710    1.7370    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650    2.1240    0.0110 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2050    3.3050    0.7980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6370    3.0040    2.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9860    1.7000    2.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190    1.3940    3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5040    2.3870    4.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580    3.6880    4.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7240    3.9980    3.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460    5.4160    2.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    2.5040   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7030    3.3320   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7760    3.6970   -3.1410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0030    4.4850   -3.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
atomoxetine

> <PRIMARY_SOM>
12

>  <Citation>
Ring et al.,30,319,2002

>  <DOI>
10.1124/dmd.30.3.319

$$$$
benzene
  MOE2008           2D

  6  6  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
benzene

> <PRIMARY_SOM>
1 2 3 4 5 6

>  <Citation>
R. Snyder et al., Toxicology and Applied Pharmacology, 1993, 122, 172-181

>  <DOI>
10.1006/taap.1993.1185

$$$$
benzo_a_pyrene
  MOE2008           3D

 20 24  0  0  0  0  0  0  0  0999 V2000
    3.8520   -0.2940   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8800   -1.7060   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    0.3960   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0690    0.4180   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    1.8130   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6750   -2.4370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1150   -2.3900   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8500    2.5080   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0550    1.8100   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.3640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -0.2710   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600   -1.7590    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3050   -1.6650   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7130   -3.8310    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1310   -3.7840   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360    2.5710   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8740    3.9020   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9350   -4.5020    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4670    3.9640   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6870    4.6290   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  5  1  0  0  0  0
  3 10  2  0  0  0  0
  4  9  2  0  0  0  0
  4 11  1  0  0  0  0
  5  8  2  0  0  0  0
  5 16  1  0  0  0  0
  6 12  2  0  0  0  0
  6 14  1  0  0  0  0
  7 13  1  0  0  0  0
  7 15  2  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  2  0  0  0  0
 17 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
benzo_a_pyrene

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
20 17

>  <Citation>
Bauer et al.,Chem. Res. Toxicol.,8,136,1995

>  <DOI>
10.1021/tx00043a018

$$$$
biochanin_A
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0020    1.3150    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0980    0.0190   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1970    1.9620    0.5200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1400    2.0230    0.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480   -0.6850   -0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650   -0.5580   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360    1.3020    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.4260    0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    0.0640   -0.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5120    0.1390    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -1.8370   -0.9380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5430   -1.8180   -0.7760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5010    2.1150    0.9530 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.4680   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9220    0.1370   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1810   -0.3610   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2920   -1.4810   -1.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -2.0960   -1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8830   -1.5910   -1.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5630   -1.9000   -1.6870 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5560   -3.0500   -2.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  2  0  0  0  0
  6 10  2  0  0  0  0
  6 12  1  0  0  0  0
  7  9  2  0  0  0  0
  8 10  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 17 20  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
biochanin_A

> <PRIMARY_SOM>
21

>  <Citation>
Tollesen et al.,J. Agric. Food Chem.,50,4783,2002

>  <DOI>
10.1021/jf025549r

$$$$
bpr0l075
  MOE2008           3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -8.0490   -0.3380   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1490   -1.3680    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7990   -1.3240   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3480   -0.1890   -0.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2240    0.8470   -1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5690    0.7870   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0180   -0.1880   -1.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600    1.0070   -1.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3290   -0.7270    0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1580   -1.9850    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8540   -2.3470    0.7180 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6130   -0.0400    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6530    1.4360    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6790   -0.6470    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6570    2.0770   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.7380    3.4700   -0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7760    4.2280    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7920    3.5750    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7420    2.1800    1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.7540    3.9760   -1.2130 O   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3550    5.0970   -0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8540    5.5970    0.1810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6060    6.1070   -0.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9180    4.3430    1.7370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9950    3.5490    2.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2 11  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
  9 12  1  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 13 15  1  0  0  0  0
 13 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 20  1  0  0  0  0
 17 18  2  0  0  0  0
 17 22  1  0  0  0  0
 18 19  1  0  0  0  0
 18 24  1  0  0  0  0
 20 21  1  0  0  0  0
 22 23  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
bpr0l075

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
21 25

> <TERTIARY_SOM>
8 3 5

>  <Citation>
Yao et al.,Drug Metab. Disp.,35,1042,2007

>  <DOI>
10.1124/dmd.106.014597

$$$$
bromodichloromethane
  MOE2008           2D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6190    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
M  END
>  <ID>
bromodichloromethane

> <PRIMARY_SOM>
1 4

>  <Citation>
John W. Allis and Guangyu Zhao, Chemico-Biological Interactions 140 (2002) 137–153

$$$$
bupropion
  MOE2008           3D

 16 16  0  0  1  0  0  0  0  0999 V2000
   -2.7640    0.4950   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6190   -0.5240   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1440   -1.8160   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8150   -2.0980   -0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -1.0750    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300    0.2280    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4750   -1.3680    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4100   -0.2620    0.6860 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.4240   -0.1570    2.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7650   -0.5580    0.2030 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    0.6630   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000    0.4500   -0.9090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    0.9830   -1.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2040    1.8280    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3680    2.1130    0.1000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8930   -2.4990    0.1390 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 15  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
M  END
>  <ID>
bupropion

> <PRIMARY_SOM>
12 13 14

>  <Citation>
Faucette et al.,Drug Metab. Disp.,28,1222,2000

$$$$
butadiene_monoxide
  MOE2008           2D

  5  5  0  0  1  0  0  0  0  0999 V2000
   -0.5450    0.4820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5300    0.2860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1150   -0.2690    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.9690    0.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920   -0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
M  END
>  <ID>
butadiene_monoxide

> <PRIMARY_SOM>
1 2

>  <Citation>
Krause and Elfarra,Arch. Biochem. Biophys.,337,176,1997

$$$$
caffeine
  MOE2008           3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    3.5950    2.6770   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3470   -1.3750    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480   -1.4160    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1170    1.0210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    0.6490   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0820   -1.1970    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8040    0.6730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8150   -0.6930    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6100    1.4500   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170   -0.7600    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8580   -0.1290    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6730   -2.8560    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6620    2.3560   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1980    1.3350   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0  0  0  0
  2 10  2  0  0  0  0
  3  8  1  0  0  0  0
  3 10  1  0  0  0  0
  3 12  1  0  0  0  0
  4  7  1  0  0  0  0
  4 11  1  0  0  0  0
  4 13  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 14  1  0  0  0  0
  6  8  1  0  0  0  0
  6 11  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
M  END
>  <ID>
caffeine

> <PRIMARY_SOM>
11 6

> <SECONDARY_SOM>
14

> <TERTIARY_SOM>
13

>  <Citation>
Ha et al.,Eur. J. Clin. Pharmacol.,49,309,1996

$$$$
capsaicin
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.0890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1120    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    1.4200   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7530    2.3420    1.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0350   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -2.0400   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9090    2.9870    1.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5940   -0.6250   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1300   -2.4740   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3410    3.2240    3.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020    3.3760    0.7430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6770    3.9690    3.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1160    4.2090    4.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4520    4.9540    4.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8840    5.1910    5.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1560    6.4060    6.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5880    6.6430    7.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5940    7.5840    8.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9810    7.2760    7.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 10 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
capsaicin

> <PRIMARY_SOM>
2 3 4 6 7 20 21 22

>  <Citation>
Reilly et al.,Chem. Res. Toxicol.,16,336,2003

>  <DOI>
10.1021/tx025599q

$$$$
carvedilol
  MOE2008           3D

 30 33  0  0  1  0  0  0  0  0999 V2000
   -3.7140   -1.3820    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0840   -1.3100    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650   -2.7190    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6960   -0.4240    0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5460   -2.6120   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0030   -0.2410    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4900   -3.4630   -0.1440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0480   -3.1650    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810   -0.8760    0.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430    0.8830    0.7060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8950   -2.9010   -0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3500   -0.5160   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -2.2250    0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8560    1.8220    0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7990   -1.8350   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800    2.3260   -0.5270 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0850    3.1520   -0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    3.1290   -1.0990 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9390    2.2590    0.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850    2.8460    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    1.6950    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6160    2.0490    0.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7310    1.2810    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8870   -0.1450   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8810    2.0790    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1770   -0.6550   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930   -1.0840   -0.0710 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1620    1.5450   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3170    0.1590   -0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060   -2.5390   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  8 13  2  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 15  2  0  0  0  0
 12 15  1  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  2  0  0  0  0
 23 25  1  0  0  0  0
 24 26  1  0  0  0  0
 24 27  1  0  0  0  0
 25 28  2  0  0  0  0
 26 29  2  0  0  0  0
 27 30  1  0  0  0  0
 28 29  1  0  0  0  0
M  END
>  <ID>
carvedilol

> <PRIMARY_SOM>
30

> <SECONDARY_SOM>
28 29

>  <Citation>
Oldham and Clarke,Drug Metab. Disp.,25,970,1997

$$$$
chlorpromazine_compound_1
  MOE2008           3D

 26 28  0  0  1  0  0  0  0  0999 V2000
    9.1370   -0.0500    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7590   -0.0940   -0.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.1180   -0.2330    1.1820 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.7140    1.2350    0.4130 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170   -4.1990    0.6400 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.3690   -1.2370   -0.3460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1970    0.1500   -0.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8690    1.0070    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7240    2.4440    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4070    3.2900    1.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    4.7350    0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9600    5.5740    1.9540 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170    5.2680    2.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9300    6.9450    1.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6640   -1.6230    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2210   -2.0490   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9450   -2.9200    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2520   -3.3910    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7330   -0.7130   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9930   -1.5400   -0.8360 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2480   -3.2690    0.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0910   -4.1720   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0320   -1.0510    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8390   -2.3190   -0.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2850   -2.3450    0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8890   -3.6420   -0.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1 23  1  0  0  0  0
  5 17  1  0  0  0  0
  5 18  1  0  0  0  0
  6  7  1  0  0  0  0
  6 15  1  0  0  0  0
  6 16  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 15 17  2  0  0  0  0
 15 19  1  0  0  0  0
 16 18  2  0  0  0  0
 16 20  1  0  0  0  0
 17 21  1  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 20 24  2  0  0  0  0
 21 25  2  0  0  0  0
 22 26  2  0  0  0  0
 23 25  1  0  0  0  0
 24 26  1  0  0  0  0
M  END
>  <ID>
chlorpromazine_compound_1

> <PRIMARY_SOM>
5

>  <Citation>
Cashman et al.,Drug Metab. Disp.,21,492,1993

$$$$
chlorzoxazone
  MOE2008           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.3330    0.6250    0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120    1.4210    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0080    0.7740   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940   -1.3800   -0.3940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0710   -0.6280   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710   -1.4210   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530   -0.7460    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300   -1.2400    0.3190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.1320    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5690   -0.1620    0.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    1.0690    0.4690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
chlorzoxazone

> <PRIMARY_SOM>
3

>  <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

$$$$
clozapine
  MOE2008           3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -1.5480   -0.4800   -0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680   -1.2720    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8910   -0.9720    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2150    0.1130   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2140    0.9140   -1.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8860    0.6330   -0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8880    1.4970   -1.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    2.1480   -0.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0210    3.5320   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7710    4.1750    0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5200    3.4400    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.0600    1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150    1.3990    0.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7480   -0.0690    0.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2520   -0.8370    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9650   -0.6770    0.4640 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0760   -2.1420    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2120   -2.5950   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4510   -1.8980   -0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2630   -0.4760   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    0.1160    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4970   -2.3930   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1510   -1.9620    0.7300 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 15  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 23  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 21  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
clozapine

> <PRIMARY_SOM>
22

>  <Citation>
Tugnait et al.,Chemico-Bio. Inter.,118,171,1999

>  <DOI>
10.1016/S009-2797(99)00006-X

$$$$
coumarin
  MOE2008           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.2980    0.6720    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140    1.4020    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0950    0.7190   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.6730   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.3910   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.7140   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5580   -1.4270   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6970   -0.7450    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7300    0.7170    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7950    1.3150    0.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5080    1.3820    0.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
coumarin

> <PRIMARY_SOM>
7 8

>  <Citation>
Lewis et al.,Toxic.,20,256,2006

>  <DOI>
10.1016/.tiv.2005.08.001

$$$$
dacarbazine
  MOE2008           2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.4610   -1.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8740   -0.6440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220   -0.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540   -1.1870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4930    0.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9100    1.3590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2900    0.9890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1470    0.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8610   -0.3670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5760    0.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5760    0.8710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2900   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
dacarbazine

> <PRIMARY_SOM>
12 13

>  <Citation>
J. M. Reid, M. J. Kuffel, J. K. Miller, R. Rios, M. M. Ames, Clin. Cancer Res. 1999, 5, 2192-2197.

$$$$
dapsone
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0120   -0.2040   -0.1440 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160   -0.1580   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1570   -0.1410   -1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5480   -0.0970   -1.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1860   -0.0760   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4670   -0.0810    1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770   -0.1250    1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9410    0.0090    0.0500 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.5200   -1.6510    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3880    0.6040   -1.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3060    0.6170    1.3160 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7210   -2.2800    1.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2010   -3.5860    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4830   -4.2510    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9660   -5.5710    0.1470 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2840   -3.5980   -1.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8040   -2.2910   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  2  0  0  0  0
  8 11  2  0  0  0  0
  9 12  1  0  0  0  0
  9 17  2  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  2  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
dapsone

> <PRIMARY_SOM>
1 15

>  <Citation>
Mitra et al.,Clin. Pharmacol. Ther.,58,556,1995

$$$$
diallyl_disulfide
  MOE2008           3D

  8  7  0  0  0  0  0  0  0  0999 V2000
   -0.1370   -0.0860   -0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690   -0.1380    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900   -0.6460   -1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7430   -0.6450   -0.4320 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -1.3840   -2.1560 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1170   -1.3400   -1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8520   -1.8640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0750   -1.8380   -2.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
M  END
>  <ID>
diallyl_disulfide

> <PRIMARY_SOM>
4 5

>  <Citation>
Teyssier et al.,Drug Metab. Disp.,27,835,1999

$$$$
dibenzo_a_h_anthracene
  MOE2008           3D

 22 26  0  0  0  0  0  0  0  0999 V2000
    2.4280    1.4740    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500    0.7620    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510   -0.6300    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520   -1.3350    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360   -0.6560    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -1.3850    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -0.7540    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4280   -1.4730    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6500   -0.7610   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6510    0.6310   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4520    1.3350   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    0.6570   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0470    1.3850   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    0.7550    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8650    1.4450    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930    2.8370    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7020    3.5540    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    2.8770    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8650   -1.4450   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8930   -2.8370   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7020   -3.5540    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850   -2.8770    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  8 22  2  0  0  0  0
  9 10  1  0  0  0  0
  9 19  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_h_anthracene

> <PRIMARY_SOM>
3 4 10 11

> <SECONDARY_SOM>
15 16 19 20

> <TERTIARY_SOM>
17 18 21 22

>  <Citation>
Shou, M.G.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,h]Anthracene by cDNA-Expresed Human Cytochromes P450. Arch. Biochem. Biophys. 1996, 328, 201–207.

>  <DOI>
10.1006/abbi.1996.0161

$$$$
dibenzo_a_l_pyrene
  MOE2008           3D

 24 29  0  0  0  0  0  0  0  0999 V2000
   -1.8990   -1.1580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310   -2.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6090   -3.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -2.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680   -3.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800   -2.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9990   -1.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -0.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750    0.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    1.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8300    1.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    1.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200    1.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6880   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5450   -1.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.3940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9830   -3.3580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2430   -2.7730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3520   -1.3910    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1960   -0.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    1.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7320    3.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070    3.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540    3.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 20  2  0  0  0  0
  2  3  1  0  0  0  0
  2 17  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 24  2  0  0  0  0
 13 14  1  0  0  0  0
 13 21  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_l_pyrene

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
5 6 17 18

>  <Citation>
Shou, M.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,l ]pyrene by Human Recombinant Cytochromes P450, Lung and Liver Microsomes. Carcinogenesis 1996, 17, 2429–2433.

>  <DOI>
10.1093/carcin/17.11.2429

$$$$
dichloromethane
  MOE2008           3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0080   -0.0020    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7810    0.0090    0.0190 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5970    1.1760    1.1880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
M  END
>  <ID>
dichloromethane

> <PRIMARY_SOM>
1

>  <Citation>
D. Pankow, S. Jagielki, Hum. Exp. Toxicol., 1993, 12, 227-231

$$$$
dimethylformamide
  MOE2008           3D

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0550    0.3950   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110   -0.2950    0.0800 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7520   -1.0720   -1.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770   -0.2190    1.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8270    0.4000    2.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  4  5  2  0  0  0  0
M  END
>  <ID>
dimethylformamide

> <PRIMARY_SOM>
1 3

>  <Citation>
J. Mraz et al., Chem. Res. Toxicol., 1993, 6, 197-207

$$$$
diuron
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.8090   -2.6710   -0.0070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4870   -4.5490    0.0090 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1380    1.7270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970    3.5060   -0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440    1.3530   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -0.0450   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9820    2.1470   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5340   -0.6380   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9330   -0.8470    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    4.0370   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7780    4.4530   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070   -2.0260   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110   -2.2340    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -2.8280    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0  0  0  0
  2 14  1  0  0  0  0
  3  7  2  0  0  0  0
  4  7  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
diuron

> <PRIMARY_SOM>
10 11

>  <Citation>
Abass et al.,Drug Metab. Disp.,35,1634,2007

>  <DOI>
10.1124/dmd.107.016295

$$$$
enflurane
  MOE2008           3D

 10  9  0  0  1  0  0  0  0  0999 V2000
   -1.9950    0.8000   -1.0720 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180   -0.1190   -1.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4610    0.2360   -3.0980 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    0.0150   -1.4810 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4460   -0.7950   -0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0120   -2.0560   -0.5870 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8030   -0.8750   -0.5060 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -0.2640    1.0070 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5740   -0.5790    1.4920 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -0.8780    1.9220 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
M  END
>  <ID>
enflurane

> <PRIMARY_SOM>
8

>  <Citation>
Garton et al., Drug Metab. Dispos., 1995, 23, 1426-1430

$$$$
estradiol
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3770    3.0490   -0.3030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -2.8320    0.5680 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5030    1.5170    0.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4850    0.0120    0.1280 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2390   -0.7070    0.4930 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.0790   -0.1380   -0.3080 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.8620    1.7620   -0.5710 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.3360    2.0280   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8500   -0.5390   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0140    1.3800   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7010    0.6920    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3070   -2.2050    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4110    2.0860    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7840   -0.8400   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0450   -2.8500    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7810   -2.1450    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5660   -0.2330   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5710   -2.8090    0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590   -0.8960   -0.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -2.1780    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estradiol

> <PRIMARY_SOM>
14

>  <Citation>
Ohe et al.,Drug Metab. Disp.,28,110,1999

$$$$
estrone
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3430    2.8640   -0.8390 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420   -2.8500    0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470    1.6130    0.0460 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4750    0.1110    0.1180 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2310   -0.5980    0.5090 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.1380   -0.1490   -0.4530 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.9000    1.8650   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4060    2.0270   -0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8390   -0.4260   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0590    1.3520   -0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7380    0.7270    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3360   -2.1040    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1540    2.2190    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8350   -0.8490   -0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0420   -2.7180    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8060   -2.0900    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6420   -0.3100   -0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5930   -2.7560    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320   -0.9770   -0.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4230   -2.1930    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  2  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estrone

> <PRIMARY_SOM>
14

>  <Citation>
Ohe et al.,Drug Metab. Disp.,28,110,1999

$$$$
ethanol
  MOE2008           3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    2.7320    0.2590   -0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2400    0.2630   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970   -0.0840    1.0520 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
M  END
>  <ID>
ethanol

> <PRIMARY_SOM>
2

>  <Citation>
Hamitouche et al.,Toxic. Let.,167,221,2006

>  <DOI>
10.1016/j.toxlet.2006,09.011

$$$$
ethosuximide
  MOE2008           3D

 10 10  0  0  1  0  0  0  0  0999 V2000
   -1.2730   -0.2720    1.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1450   -0.9000    0.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0990   -0.2540   -0.5170 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.3250   -0.2520    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6130    1.1950    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6050    1.6210    0.9230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6040    1.9490   -0.1540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4030    1.2210   -0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3920    1.6860   -1.2530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1200   -0.9520   -1.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  8  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
M  END
>  <ID>
ethosuximide

> <PRIMARY_SOM>
2

>  <Citation>
Bachmann et al.,xenobiotica, 2003, 33, 265-276

$$$$
etoposide
  MOE2008           3D

 42 48  0  0  1  0  0  0  0  0999 V2000
    0.7860    1.3680    0.9400 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1160    0.0280    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770    1.9800    1.4420 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.1640    1.1670    2.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2980   -0.6390    0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1480   -0.5020   -0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160    0.9200    2.3960 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.9520    3.1680    2.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1000    0.0080    2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    2.1440    2.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3650   -0.1070    1.4880 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.5730   -1.8640   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4120   -1.7200   -1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6900    1.8450    3.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9170    3.0860    3.2940 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1310    4.0490    2.2510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9730   -0.1820    3.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9680    1.9620    3.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8970   -1.1780    2.2710 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6180   -2.3960   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3360   -2.4530   -2.0080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9110    0.7950    4.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9100   -1.3230    4.6420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8800    2.9240    3.7620 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3200   -1.1080    2.1540 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.6210   -3.5460   -1.6230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2450   -3.7740   -1.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7690    0.6130    5.2540 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -2.1170    4.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6910    3.9830    2.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7850    0.1050    2.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9460   -2.3130    2.8580 C   0  0  3  0  0  0  0  0  0  0  0  0
    7.1750    0.2100    2.4520 C   0  0  3  0  0  0  0  0  0  0  0  0
    7.4720   -2.2460    2.7170 C   0  0  3  0  0  0  0  0  0  0  0  0
    5.5930   -2.2920    4.2430 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9410   -0.8760    3.2160 C   0  0  3  0  0  0  0  0  0  0  0  0
    7.7110    1.5780    2.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0740   -3.2770    3.5030 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3380   -0.7130    2.9780 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1260    1.6030    2.6730 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6950    0.5750    3.4790 C   0  0  3  0  0  0  0  0  0  0  0  0
    9.1830    0.7180    4.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 11  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 17  1  0  0  0  0
 10 18  2  0  0  0  0
 11 19  1  0  0  0  0
 12 20  2  0  0  0  0
 13 20  1  0  0  0  0
 13 21  1  0  0  0  0
 14 15  1  0  0  0  0
 17 22  2  0  0  0  0
 17 23  1  0  0  0  0
 18 22  1  0  0  0  0
 18 24  1  0  0  0  0
 19 25  1  0  0  0  0
 20 26  1  0  0  0  0
 21 27  1  0  0  0  0
 22 28  1  0  0  0  0
 23 29  1  0  0  0  0
 24 30  1  0  0  0  0
 25 31  1  0  0  0  0
 25 32  1  0  0  0  0
 26 27  1  0  0  0  0
 31 33  1  0  0  0  0
 32 34  1  0  0  0  0
 32 35  1  0  0  0  0
 33 36  1  0  0  0  0
 33 37  1  0  0  0  0
 34 36  1  0  0  0  0
 34 38  1  0  0  0  0
 36 39  1  0  0  0  0
 37 40  1  0  0  0  0
 39 41  1  0  0  0  0
 40 41  1  0  0  0  0
 41 42  1  0  0  0  0
M  END
>  <ID>
etoposide

> <PRIMARY_SOM>
30 29

>  <Citation>
Kawashiro, T.; Yamashita, K.; Zhao, X.J.; Koyama, E.; Tani, M.; Chiba, K.; Ishizaki, T. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes. J. Pharmacol. Exp. Ther. 1998, 286, 1294–1300.

$$$$
eugenol
  MOE2008           3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -0.0380    1.3680    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -0.0260    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    2.0820    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0810    0.1110 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410   -0.6930   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    1.4320    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1560    3.4460    0.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3410    1.2250    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    0.0410   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -2.1840   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260   -2.7420   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -3.5230   -1.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
M  END
>  <ID>
eugenol

> <PRIMARY_SOM>
8

>  <Citation>
Sakano et al.,Mutation Res.,565,35,2004

>  <DOI>
10.1016/j.mrgentox.2004.08.009

$$$$
eupatilin
  MOE2008           3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    1.2530    0.5380    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    1.3020    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3240    2.6110    0.6240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8240    3.4440    0.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1530    0.6790    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3110    1.4060    0.1580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4640    0.6130   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700   -0.6850   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.4270   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430   -0.8260   -0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -1.5870   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4920   -2.8910   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7610   -3.6290   -0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7640   -4.8230   -0.7810 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9880   -2.8610   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -1.5040    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480   -0.8560    0.1060 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2640   -3.4330   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4300   -4.7610   -0.5460 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4050   -2.6590   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6140   -3.3020   -0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5670   -2.5390   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2430   -1.3100    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3050   -0.5160    0.6240 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9800   -0.7290    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 11 17  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 18  2  0  0  0  0
 16 17  1  0  0  0  0
 16 25  2  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
 20 23  2  0  0  0  0
 21 22  1  0  0  0  0
 23 24  1  0  0  0  0
 23 25  1  0  0  0  0
M  END
>  <ID>
eupatilin

> <PRIMARY_SOM>
7

>  <Citation>
H. S. LEE, H. Y. JI, E. J. PARK, & S. Y. KIM, Xenobiotica, August 2007; 37(8): 803–817

>  <DOI>
10.1124/dmd.104.001743

$$$$
furan
  MOE2008           2D

  5  5  0  0  0  0  0  0  0  0999 V2000
    0.9770    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3730    1.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2080    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3730   -1.1490    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
M  END
>  <ID>
furan

> <PRIMARY_SOM>
3 5

>  <Citation>
G.L. Kedderis et al., Toxicology and Applied Pharmacology, 1993, 123, 274-282

$$$$
halothane
  MOE2008           3D

  7  6  0  0  1  0  0  0  0  0999 V2000
    0.1040   -0.1670    0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -0.1470    0.4390 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.7030    1.3300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010   -1.4020    0.7590 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    0.2250   -0.9860 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1750    0.2560   -1.0660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2770   -1.0090   -2.3420 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
M  END
>  <ID>
halothane

> <PRIMARY_SOM>
5

>  <Citation>
Spracklin et al.,J. Pharma. Exp. Thera.,281,400,1997

$$$$
hexane
  MOE2008           3D

  6  5  0  0  0  0  0  0  0  0999 V2000
   -0.3740   -0.3580   -0.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490    0.0580    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4990   -0.3390    1.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -1.7720    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6410   -2.8150    0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0590   -2.6050    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
hexane

> <PRIMARY_SOM>
2 5

>  <Citation>
M.M. Iba, J. Fung, F.J. Gonzalez, Arch. Toxicol., 2000, 74, 582-586

>  <DOI>
10.1007/s002040000182

$$$$
iloperidone
  MOE2008           3D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -6.2880   -0.1390   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0790    0.2990    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5460   -1.1250   -1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8150   -1.2960   -1.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8540   -0.4960   -1.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6190    0.4840   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3360    0.6680    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1040   -0.6780   -1.6500 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8050    1.5190    1.1740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4190    1.2700    1.2920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940   -0.2720    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1990   -0.8170    1.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520   -1.2900    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8980   -0.1610    1.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3160    0.2690   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7390    0.8280   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -0.6900    1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4150    0.4420    0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8360   -0.1080    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7220    0.9490    0.0960 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9600    0.4030   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1440   -0.9520    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3970   -1.5110    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4910   -0.7140   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3050    0.6530   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0440    1.2040   -0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8290   -1.3080   -0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8590    2.5290   -0.6180 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1370    3.0680   -0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7750   -0.6150   -0.6580 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0270   -2.7780   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  2 10  2  0  0  0  0
  2 11  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 26  2  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
 24 25  2  0  0  0  0
 24 27  1  0  0  0  0
 25 26  1  0  0  0  0
 26 28  1  0  0  0  0
 27 30  2  0  0  0  0
 27 31  1  0  0  0  0
 28 29  1  0  0  0  0
M  END
>  <ID>
iloperidone

> <PRIMARY_SOM>
27 30

>  <Citation>
Mutlib et al.,J. Pharm. Exp. Ther.,286,1285,1998

$$$$
indole
  MOE2008           3D

  9 10  0  0  0  0  0  0  0  0999 V2000
    1.4350    4.1220   -4.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5180    3.9210   -3.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    2.8300   -3.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2760    1.9510   -4.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    2.1270   -5.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040    3.2340   -5.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4320    1.0560   -6.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5770    0.2630   -5.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9970    0.8120   -4.6100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
indole

> <PRIMARY_SOM>
7 8

> <SECONDARY_SOM>
2

>  <Citation>
Gillam et al., Biochemistry, 2000, 39, 13817-13824

$$$$
lauric_acid
  MOE2008           3D

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.5190    0.5000   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3010    0.4360    0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7550   -0.6000    1.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4910   -1.9620    1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6330   -2.5340    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9880   -2.4820    0.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0170   -2.9950    2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3490   -4.3360    2.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7500   -5.4150    1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2410   -5.5800    1.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0230   -5.6260    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0490   -7.0270    3.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8910   -7.8640    2.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0110   -7.2380    3.9890 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
lauric_acid

> <PRIMARY_SOM>
2

>  <Citation>
Imaoka et al.,Biochem. Pharma.,51,1041,1996

>  <DOI>
10.1016/0006-2952(96)00052-4

$$$$
linoleic_acid
  MOE2008           3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4170    2.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4120   -0.5260    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3960    3.5850    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8100   -1.3580   -0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8310    4.1150   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2240   -1.8800   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8110    5.6450    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8760   -1.5900   -2.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2460    6.1740   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4080   -2.5650   -2.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260    7.6810    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0600   -2.2760   -4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1710    8.2710    0.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3790    8.3680   -0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4290   -3.1560   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0910   -2.8620   -6.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -3.7420   -7.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1220   -3.4490   -9.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  2  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
linoleic_acid

> <PRIMARY_SOM>
19

> <SECONDARY_SOM>
20

>  <Citation>
Adas et al., J. Lip. Res., 1999, 40, 1990-1997

$$$$
m-xylene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1590    1.5910    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
m-xylene

> <PRIMARY_SOM>
5 8

>  <Citation>
Tassaneeyakul et al., J. Pharm. Exp. Ther., 1996, 276, 101-108

$$$$
mde
  MOE2008           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
    0.1140    1.1540    0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0540    0.2290   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3460    1.7130    0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0450    1.4320    0.9270 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9970   -0.1900   -1.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3410   -0.1920   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4360    1.3050   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    0.5630    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    0.3620   -1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8080    1.8600   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1060    2.3590    1.3840 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.3720    1.2300    2.2660 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3190    3.2620    1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4710    1.7100    3.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7430    0.5280    4.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
mde

> <PRIMARY_SOM>
8

>  <Citation>
Kreth et al.,Biochem. Pharm.,59,1563,2000

>  <DOI>
10.1016/S0006-2952(00)00284-7

$$$$
melatonin
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8270   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0840    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -0.7060    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    0.7120   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8920    3.2460    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3690    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950   -0.0240    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9580    3.7610    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070    2.0270    0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4510    5.1410    1.4430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0300    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5920    5.8030    2.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0990    7.2220    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    5.2570    3.6540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  6 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
melatonin

> <PRIMARY_SOM>
10

>  <Citation>
X. C. Ma, J. R. Idle, K. W. Krausz, F. J. Gonzalez, Drug Metab. Dispos. 2005, 33, 489-494.

>  <DOI>
10.1124/dmd.104.002410

$$$$
methiocarb
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0250    1.3690    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200   -0.0110   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    2.0590    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0460    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770   -0.6990   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    1.3730    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270    1.9390    1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -0.0090   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -2.1980   -0.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6710    2.1230    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460    2.5130    1.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    1.3240    2.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050   -0.8860   -0.0730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1420    2.3960    2.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -0.8580   -1.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 12  2  0  0  0  0
  8 13  1  0  0  0  0
 11 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
methiocarb

> <PRIMARY_SOM>
13

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
methoxychlor_mono_OH
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
methoxychlor_mono_OH

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
14 15

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
methyleugenol
  MOE2008           3D

 13 13  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3880    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    2.0530    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -0.7020    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4150   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1460    3.4810    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3990    0.0340   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690   -2.1270    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6760    2.1850   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1210    2.4340    1.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3150    2.0570    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7  9  1  0  0  0  0
  7 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <ID>
methyleugenol

> <PRIMARY_SOM>
11

>  <Citation>
Gardner et al., Carcinogenesis, 1997, 18, 1775-1783

$$$$
methylformamide
  MOE2008           3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0550    0.4020    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090   -0.2960    0.0740 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0720   -0.2180    1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8230    0.4010    2.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
M  END
>  <ID>
methylformamide

> <PRIMARY_SOM>
2 3

>  <Citation>
R. Hyland et al., Molecular Pharmacology, 1992, 41, 259-266

$$$$
myristic_acid
  MOE2008           3D

 16 15  0  0  0  0  0  0  0  0999 V2000
   -4.0250    2.2670    6.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5080    1.5490    5.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0280    2.2720    3.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5150    3.7190    3.8250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9890    3.7180    3.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4760    2.9950    2.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9910    3.7100    1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4790    5.1640    1.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0570    5.1620    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5610    4.4430    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0450    5.1610   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640    6.6020   -1.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0900    6.5990   -1.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5450    5.9610   -2.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    5.5000   -3.0860 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8580    5.8350   -2.4930 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
myristic_acid

> <PRIMARY_SOM>
2

>  <Citation>
Adas et al., J. Lip. Res., 1999, 40, 1990-1997

$$$$
nabumetone
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1850    1.3840   -0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1530   -0.0250   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9950    2.0910   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950    2.0560    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330   -0.7320    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0580   -0.6960   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    1.4170   -0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    1.3390    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420   -0.0540    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2300    0.0220   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4360    2.2240   -0.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6420   -0.8360    0.5450 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.5970   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.0470    0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8810    1.5910    1.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5260    2.8500    1.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360    0.6150    1.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
nabumetone

> <PRIMARY_SOM>
16

>  <Citation>
Turpeinen et al.,Drug Metab. Disp.,37,1017,2009

>  <DOI>
10.1124/dmd.108.025700

$$$$
nicardipine
  MOE2008           3D

 35 37  0  0  1  0  0  0  0  0999 V2000
    0.4840    1.2560   -0.4290 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0690   -0.1930   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    1.4680   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    1.9000   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -0.5650    0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5350   -1.1680   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    1.9570   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5500    1.1140    1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3970   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.9810   -1.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1640   -1.9000    0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510   -2.5010   -1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    2.3860   -2.4610 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000    2.1000   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450    1.9680    1.4020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    0.2070    1.7610 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840    3.0490   -3.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    1.7490   -3.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2430    2.1700   -0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7020   -2.8750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -2.2870    1.9280 N   0  3  0  0  0  0  0  0  0  0  0  0
    4.1550    1.6340    2.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110    1.7770   -3.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6020   -1.3850    2.5740 O   0  5  0  0  0  0  0  0  0  0  0  0
   -2.2120   -3.4990    2.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1330    0.4760    2.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2770    0.7730    1.6420 N   0  0  3  0  0  0  0  0  0  0  0  0
    7.0530    1.8480    2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1050   -0.4220    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580    2.5380    1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4510    3.5100    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3160    2.2210    1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2960    4.1560   -0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1610    2.8670    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6500    3.8340   -0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  2  0  0  0  0
 11 21  1  0  0  0  0
 12 20  1  0  0  0  0
 15 22  1  0  0  0  0
 18 23  1  0  0  0  0
 21 24  1  0  0  0  0
 21 25  2  0  0  0  0
 22 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
 30 32  1  0  0  0  0
 31 33  1  0  0  0  0
 32 34  2  0  0  0  0
 33 35  2  0  0  0  0
 34 35  1  0  0  0  0
M  CHG  1  21   1
M  CHG  1  24  -1
M  END
>  <ID>
nicardipine

> <PRIMARY_SOM>
28

>  <Citation>
Nakamura et al.,Biol. Pharm. Bull.,28,882,2005

>  <DOI>
10.1248/bpb.28.882

$$$$
nicotine
  MOE2008           3D

 12 13  0  0  1  0  0  0  0  0999 V2000
    1.1240    0.6150   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1580    1.2470    0.6500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0140    0.5900    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5920   -1.2980    0.4680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2680   -0.6650    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420   -1.2800   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -0.6390   -0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7190   -0.9130   -0.3960 N   0  0  3  0  0  0  0  0  0  0  0  0
   -3.2950   -0.5140   -1.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -2.1420   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1360   -2.9830    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   -2.8070    0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 12  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
nicotine

> <PRIMARY_SOM>
10

>  <Citation>
Yamazaki et al.,Arch. Toxicol.,73,65,1999

>  <DOI>
10.1007/s002040050588

$$$$
norverapamil
  MOE2008           3D

 32 33  0  0  1  0  0  0  0  0999 V2000
   -6.3400    1.9440   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5860    1.3130   -0.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6490   -0.0770   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4640   -0.8060    0.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4420    3.1130    0.5210 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8660    2.0760    0.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8890   -0.6610   -0.0070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7680    1.9950   -0.3330 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3910   -2.0150    1.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4510   -2.5270   -0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5180   -3.7010   -0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2880   -2.0130   -1.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5430    1.7510    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8090    1.2080    0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500   -0.1750    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8430   -1.0130    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -0.4910    0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4410    0.8970    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3610   -1.4190    0.5130 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.0800   -0.5900    0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7850   -1.3630    0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3750   -0.4130    0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6000   -1.1870    0.3280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6990   -0.2510    0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9990   -1.0210    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2190   -0.1760    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1670    1.2060   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1070    3.5220    0.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0890    1.3920   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8040   -2.0700    0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5550    3.3920   -0.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4100   -2.4810    2.9350 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 27  2  0  0  0  0
  2  3  2  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4 26  2  0  0  0  0
  5 13  1  0  0  0  0
  5 28  1  0  0  0  0
  6 14  1  0  0  0  0
  6 29  1  0  0  0  0
  7 30  1  0  0  0  0
  8 31  1  0  0  0  0
  9 19  1  0  0  0  0
  9 32  3  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 19  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
M  END
>  <ID>
norverapamil

> <PRIMARY_SOM>
24

>  <Citation>
Tracy et al.,Br. J. Clin. Pharmacol.,47,545,1999

>  <DOI>
10.1046/j.136502125.1999.00923.x.

$$$$
o-phenylphenol
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.9830    2.1830    0.7750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520   -0.1310    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250   -0.1760    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5380    0.9910    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560   -1.2880   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010    0.9030    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190   -1.3300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9330    0.9640    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8480   -1.3320   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950    0.8450    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -1.4060   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5890   -0.2000   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -0.3140    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  2  0  0  0  0
  8 12  2  0  0  0  0
  9 12  1  0  0  0  0
 10 13  2  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
o-phenylphenol

> <PRIMARY_SOM>
9

>  <Citation>
Ozawa et al.,Xenobiotica,30,1005,2000

>  <DOI>
10.1080/00498250050200159

$$$$
o-xylene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6940    1.5640    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
o-xylene

> <PRIMARY_SOM>
6 8

>  <Citation>
Tassaneeyakul et al., J. Pharm. Exp. Ther., 1996, 276, 101-108

$$$$
oleic_acid
  MOE2008           3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -2.6610    2.3610    0.7480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1450    1.6430   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6640    2.3660   -1.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520    3.8120   -1.7500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6260    3.8120   -1.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1120    3.0880   -3.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6280    3.8030   -4.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150    5.2580   -4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500    5.2550   -4.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9750    3.9900   -4.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180    2.6870   -4.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3450    2.5990   -5.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2230    2.6860   -6.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2130    1.5160   -6.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4580    0.1950   -6.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680    0.1050   -7.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600    0.1970   -9.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3370   -0.8390   -9.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3330   -1.6340   -8.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2150   -0.9710  -10.2490 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
oleic_acid

> <PRIMARY_SOM>
2

> <SECONDARY_SOM>
1

>  <Citation>
Adas et al., J. Lip. Res., 1999, 40, 1990-1997

$$$$
ortho_dichlorobenzene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
   -0.0130    1.0760    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    1.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580    3.1650    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0480    3.8410    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2380    3.1330    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2190    1.7500    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0710    5.5770    0.0320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7540    3.9810    0.0490 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
M  END
>  <ID>
ortho_dichlorobenzene

> <PRIMARY_SOM>
1 2

> <SECONDARY_SOM>
3 6

>  <Citation>
Bogaards, J.J.P.; Omen, B.V.; Wolf, C.R.; Van Bladeren, P.J. Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes. Toxicol. Appl. Pharamcol. 1995, 132, 44–52.

$$$$
p-xylene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5870    4.0540    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
p-xylene

> <PRIMARY_SOM>
4 8

>  <Citation>
Tassaneeyakul et al., J. Pharm. Exp. Ther., 1996, 276, 101-108

$$$$
palmitic_acid
  MOE2008           3D

 18 17  0  0  0  0  0  0  0  0999 V2000
   -3.9720    1.2040    6.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4550    0.4850    4.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750    1.2090    3.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4620    2.6550    3.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9360    2.6550    3.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4230    1.9310    2.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9380    2.6460    1.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4250    4.1000    1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100    4.0980    1.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140    3.3790   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0990    4.0970   -1.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6180    5.5380   -1.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    5.5360   -1.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550    4.8170   -2.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    5.5360   -3.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5940    6.8160   -3.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3020    7.2160   -2.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    7.6400   -4.7640 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
palmitic_acid

> <PRIMARY_SOM>
2

>  <Citation>
Adas et al., J. Lip. Res., 1999, 40, 1990-1997

$$$$
para_cresol
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0670    0.0110   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9460   -0.7310    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3200   -0.6150    0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7980    0.2450   -0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9350    0.9910   -1.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5620    0.8710   -1.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4020   -0.1140    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430    0.3600   -0.5970 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
para_cresol

> <PRIMARY_SOM>
3 5

> <SECONDARY_SOM>
7

>  <Citation>
Yan et al.,Drug Metab. Disp.,33,1867,2005

>  <DOI>
10.1124/dmd.105.006387

$$$$
parathion
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.9290    0.1620 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    0.5790    0.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5230    1.4100   -0.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    2.1230   -1.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1080    3.4820    1.3270 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1520   -0.1220    1.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210    0.2970   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2870    3.1600   -2.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9370   -1.1930    2.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0330    0.1850    2.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9540   -0.0440   -1.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    3.1510   -3.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -1.9580    3.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.5730    3.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6400   -1.6380    4.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0550   -2.4310    5.1580 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.3190   -3.3640    5.5080 O   0  5  0  0  0  0  0  0  0  0  0  0
    2.1190   -2.1260    5.7130 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
M  CHG  1  16   1
M  CHG  1  17  -1
M  END
>  <ID>
parathion

> <PRIMARY_SOM>
1 5

>  <Citation>
Mutch et al.,Toxicology,224,22,2006

>  <DOI>
10.1016/j.tox.2006.04.024

$$$$
perazine
  MOE2008           3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3900    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    2.1590    0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0000   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    2.0730    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3540    1.7290   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680    3.3850    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -0.6710   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -0.7200    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8160    2.1910    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050    0.1890   -1.2380 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    2.5340   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1940    4.1760    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610   -2.0600   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1140   -2.0990    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1700    2.9040    1.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010    3.7500    0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0350   -2.7680   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530    3.0180    2.8520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9120    2.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.6890    3.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4500    3.9810    4.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7790    1.7590    4.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440    2.6530    4.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4270    2.7670    5.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
perazine

> <PRIMARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Europ. Neuropsychopharm.,14,199,2004

>  <DOI>
10.1016/S0924-977X(03)00105-6

$$$$
phenacetin
  MOE2008           2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    2.8660   -2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2 12  2  0  0  0  0
  3  4  1  0  0  0  0
  3 12  1  0  0  0  0
  4  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  2  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
phenacetin

> <PRIMARY_SOM>
10

>  <Citation>
M. Nakajima et al., Xenobiotica, 1999, 29, 885-898

>  <DOI>
10.1080/004982599238137

$$$$
phenanthrene
  MOE2008           2D

 14 16  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    3.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  1  0  0  0  0
  2 11  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
phenanthrene

> <PRIMARY_SOM>
4 5

> <SECONDARY_SOM>
7 8 9 10 11 12 13 14

>  <Citation>
Shou et al., Canc. Lett. 1994, 83, 305-313

>  <DOI>
10.1016/0304-3835(94)90334-4

$$$$
phenol
  MOE2008           3D

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.6250   -0.0310   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7370   -0.0220   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4190   -1.1990   -0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7340   -2.3770   -0.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6240   -2.3810   -0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3120   -1.2040   -0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6390   -1.2090   -0.3340 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
phenol

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
1 5

>  <Citation>
Seaton et al., Carcinogenesis, 1994, 15, 1799-1806

$$$$
phenytoin
  MOE2008           3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.0570    1.5580    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2250    0.2250    0.2410 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4370    1.7730   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -0.4240    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    0.4090    0.0580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9220    2.4070    0.1260 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490   -1.6320    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    2.4210   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9550    2.6060    1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7410    1.8750   -2.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0900    3.5590   -1.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0640    2.1880    1.8550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250    3.7900    1.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3920    4.1530   -2.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5380    2.9510    2.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    4.5530    2.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0430    2.4700   -3.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    3.6110   -3.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9050    4.1330    3.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  2  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  8 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 12  2  0  0  0  0
  9 13  1  0  0  0  0
 10 17  1  0  0  0  0
 11 14  2  0  0  0  0
 12 15  1  0  0  0  0
 13 16  2  0  0  0  0
 14 18  1  0  0  0  0
 15 19  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  2  0  0  0  0
M  END
>  <ID>
phenytoin

> <PRIMARY_SOM>
14 15 16 17 18 19

>  <Citation>
Komatsu et al.,Drug Metab. Disp.,28,1361,2000

$$$$
promazine
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0430    1.5840    0.0510 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    2.4400    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690    0.1900   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    2.2060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.9520    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770    3.8260    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2760   -0.5260   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1230   -0.5360   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7560    2.2410    1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8770    0.2290   -0.0190 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500    2.8320    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0540    4.7000    0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -1.9130   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310   -1.9160   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1070    2.9140    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    4.2000    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.6070   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6150    2.9690    2.9600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940    3.8840    3.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9430    3.5530    2.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
promazine

> <PRIMARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Br. J. Pharm.,138,1465,2003

>  <DOI>
10.1038/sj.bjp.0705195

$$$$
propofol
  MOE2008           3D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.2200    0.7140    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.4740    0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    1.1810    1.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4290    1.1690   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    2.7620    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    0.7100   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4950    1.4650   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1880    1.1570   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4210    1.1700    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930   -0.6880   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.3830    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6840    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  1 13  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
propofol

> <PRIMARY_SOM>
12

>  <Citation>
Court et al.,Anesthesiology,94,110,2001

$$$$
prostaglandin_H2
  MOE2008           3D

 25 26  0  0  1  0  0  0  0  0999 V2000
    5.0520    0.6840   -0.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.3840   -0.4900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400   -1.7380    0.2410 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4330   -3.9810   -4.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740   -5.1030   -3.0890 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9610   -1.4620   -0.2230 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6060   -0.7110   -0.3310 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.8540   -0.4000    0.4440 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.9330    0.6020    0.4090 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9410    0.2260    1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4800   -1.9450   -1.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4770   -1.4640    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8250   -2.6170   -1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3580   -1.8080   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7760   -2.5650    0.2690 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.0830   -3.9180   -1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1160   -3.8630   -0.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0210   -4.9420   -1.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -4.9950   -0.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4130   -6.2670   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9700   -6.0740   -2.1330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5340   -7.4230   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7110   -5.5960   -3.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2090   -8.6550   -1.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870   -4.8840   -3.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  1  0  0  0  0
  2  9  1  0  0  0  0
  3 15  1  0  0  0  0
  4 25  1  0  0  0  0
  5 25  2  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 11  1  0  0  0  0
  7  9  1  0  0  0  0
  7 12  1  0  0  0  0
  8 10  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  2  0  0  0  0
 13 16  2  0  0  0  0
 14 15  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 21  1  0  0  0  0
 19 20  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  1  0  0  0  0
 23 25  1  0  0  0  0
M  END
>  <ID>
prostaglandin_H2

> <PRIMARY_SOM>
8 9

>  <Citation>
Plastaras, J.P.; Guengerich, F.P.; Nebert, D.W.; Marnett, L.J. Xenobiotic Metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and Mutagen, Malondialdehyde. J. Biol. Chem. 2000, 275, 11784–11790.

>  <DOI>
10.1074/jbc.275.16.11784

$$$$
quinidine
  MOE2008           3D

 24 27  0  0  1  0  0  0  0  0999 V2000
   -2.6110   -1.5550    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8000   -0.9930   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9360    0.3540   -0.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8680    1.2010   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6620    0.6310    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5530   -0.7630    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750    2.5280   -0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9840    3.3230   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7720    2.8280    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5960    1.4820    0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7050    0.9220    1.0970 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8220    1.2200    0.0940 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.5400    0.5230   -1.1540 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.4730   -0.9120   -0.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7960   -1.4450   -0.3640 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.7850   -0.2770   -0.2380 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.1590    0.7750    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5680   -2.0660    0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8490   -3.3310    1.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9530    0.3520   -1.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5840    0.8150   -2.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5080   -2.9050    0.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7570   -3.4540   -0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0200    1.5270    2.3530 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 22  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 24  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  1  0  0  0  0
 13 14  1  0  0  0  0
 13 21  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 18  1  0  0  0  0
 16 17  1  0  0  0  0
 16 20  1  0  0  0  0
 18 19  2  0  0  0  0
 20 21  1  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
quinidine

> <PRIMARY_SOM>
13

>  <Citation>
Nielsen et al.,J. Pharmacol. Exp. Ther.,289,31,1999

$$$$
quinoline
  MOE2008           3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0210    0.6400   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.7540   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    1.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.3740    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.4600   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090   -1.4360   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.6780   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440    0.6720   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440   -0.7300    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3580   -0.7260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
quinoline

> <PRIMARY_SOM>
7

> <SECONDARY_SOM>
4 8

> <TERTIARY_SOM>
6

>  <Citation>
Reigh et al., Carcinogenesis, 1996, 17, 1989-1996

$$$$
rabeprazole_thioether
  MOE2008           3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0830    1.2680    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -0.0140   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1930    1.7400    0.1980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260    2.3220    0.3360 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1100    1.6960    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7460    1.0830    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7120    1.9050   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -0.3900   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0430    0.6940   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7080    2.0160    1.3870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9840    2.4790   -1.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9380    2.5700    1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6120    2.8200    0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5470    2.6750   -2.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3580    3.4700   -3.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0170    1.5260   -2.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7590   -1.6470   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1890    4.2790   -4.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4350    0.6110   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8340    3.2750   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7230    4.1080   -3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4720    4.8780   -4.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680   -0.6510   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1520   -1.7570   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  6  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  2  0  0  0  0
  8 17  1  0  0  0  0
  9 19  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 20  1  0  0  0  0
 15 20  1  0  0  0  0
 15 21  1  0  0  0  0
 17 24  2  0  0  0  0
 18 21  1  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
rabeprazole_thioether

> <PRIMARY_SOM>
4

> <SECONDARY_SOM>
22

>  <Citation>
Miura et al.,Eur. J. Clin. Pharmacol.,62,113,2006

>  <DOI>
10.1007/s00228-005-0077-8

$$$$
rosiglitazone
  MOE2008           3D

 25 27  0  0  1  0  0  0  0  0999 V2000
   -0.0160    1.3420    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0790    2.0830    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420   -0.4080   -0.0170 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    1.3110   -0.0140 C   0  0  3  0  0  0  0  0  0  0  0  0
    9.3200   -4.4040    0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5780   -4.5610    1.8480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -0.7670    0.0070 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7360   -3.2470   -0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0400    3.2950    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930    1.6050   -1.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5320    0.9190   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9900   -0.3420   -1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6790   -0.3680   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6130    1.5790   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8420    0.9520   -0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9050   -1.0000   -1.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1980   -0.9610   -0.9740 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0300   -2.2620   -1.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3600   -3.0160   -1.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6430   -5.3890   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2020   -5.6440    2.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5490   -2.2590    0.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2360   -6.5350    0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5210   -6.6590    1.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  2  0  0  0  0
  3  5  1  0  0  0  0
  3 10  2  0  0  0  0
  4  5  1  0  0  0  0
  5 11  1  0  0  0  0
  6  7  2  0  0  0  0
  6  9  1  0  0  0  0
  6 21  1  0  0  0  0
  7 22  1  0  0  0  0
  9 20  1  0  0  0  0
  9 23  1  0  0  0  0
 11 12  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  2  0  0  0  0
 13 16  2  0  0  0  0
 13 17  1  0  0  0  0
 13 18  1  0  0  0  0
 14 17  2  0  0  0  0
 15 16  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 21 24  2  0  0  0  0
 22 25  2  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
rosiglitazone

> <PRIMARY_SOM>
23

> <SECONDARY_SOM>
25

>  <Citation>
Baldwin et al.,Brit. J. Clin. Pharm.,48,424,1999

$$$$
safrole
  MOE2008           3D

 12 13  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950    2.0240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6310   -0.6730    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0310    2.2700   -1.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0520    2.2620    1.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3310    2.7490   -1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3490    2.7410    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9940    2.9830   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1690    3.0660   -2.2450 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2480    3.4470   -0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2030    3.8820   -1.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  2  0  0  0  0
  3  5  2  0  0  0  0
  3  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
safrole

> <PRIMARY_SOM>
1

>  <Citation>
Ueng et al.,Chem. Res. Toxicol.,17,1151,2004

>  <DOI>
10.1021/tx030055p

$$$$
salicylate
  MOE2008           3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -0.1620    0.2560    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5670   -0.9420    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9540   -0.9020    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6120    0.3110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8950    1.4970   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5170    1.4770   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6350    0.2270    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220   -0.8380    0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3320    1.3800   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0800   -2.1340    0.0320 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
M  END
>  <ID>
salicylate

> <PRIMARY_SOM>
5

>  <Citation>
Dupont et al., Drug Metab. Dispos., 1999, 27, 322-326

$$$$
selegiline
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
    3.7100    1.4800    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9440    0.2810   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200   -0.6550   -0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.4050   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4320    0.8000    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.7400    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -1.4520   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660   -1.2830    0.2630 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5700   -0.1870   -0.2590 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6710   -1.2840    1.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7140   -0.3550   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6520    0.9880    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2720    2.0080    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9040   -0.2580    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 12 13  3  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
selegiline

> <PRIMARY_SOM>
11

>  <Citation>
Benetton et al., Drug Metab. Pharma.,2,78,2007

>  <DOI>
10.2133/dmpk.22.78

$$$$
sertraline
  MOE2008           3D

 20 22  0  0  1  0  0  0  0  0999 V2000
   -2.6400    8.7890    2.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3890    7.7420    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3700    8.5450    3.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700    6.4500    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6020    6.1870    2.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8450    7.2490    3.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    4.7890    2.4670 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5370    7.0210    3.5880 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2020    5.9260    2.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210    4.6270    2.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8650    3.7630    3.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5970    2.8260    2.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    1.8690    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9120    3.7320    4.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    2.7760    5.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4080    1.8420    4.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5260    6.6110    4.9900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3830    0.6260    5.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.6750    2.8170    6.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2510    7.7690    5.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 13 16  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 18  1  0  0  0  0
 17 20  1  0  0  0  0
M  END
>  <ID>
sertraline

> <PRIMARY_SOM>
20

>  <Citation>
Obach et al.,Drug Metab. Disp.,33,262,2005
Kobayashi et al.,Drug Metab. Disp.,27,763,1999

>  <DOI>
10.1124/dmd.104.002428

$$$$
stearic_acid
  MOE2008           3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -4.5850    0.9220    6.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0680    0.2040    5.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5880    0.9270    4.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0750    2.3730    4.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5490    2.3730    4.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0360    1.6490    3.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5510    2.3640    1.8280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0380    3.8180    1.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5030    3.8160    1.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0010    3.0970    0.5670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5140    3.8150   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    5.2560   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    5.2540   -0.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0420    4.5350   -1.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5370    5.2540   -3.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0380    6.6950   -3.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5780    6.6980   -3.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0320    6.0600   -4.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420    5.6000   -5.0820 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3460    5.9300   -4.4880 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
stearic_acid

> <PRIMARY_SOM>
2

>  <Citation>
Adas et al., J. Lip. Res., 1999, 40, 1990-1997

$$$$
styrene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.1560    0.6760   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    1.4440   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500    2.8720   -0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.5830   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1130    0.8270    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.5390    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0300   -1.2970    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630   -0.6900   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
styrene

> <PRIMARY_SOM>
3 4

>  <Citation>
Nakajima et al.,Chem. Res. Toxicol.,7,891,1994

>  <DOI>
10.1021/tx00042a026

$$$$
tamoxifen
  MOE2008           3D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -0.0590    1.3520   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0030    0.0160    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860    2.1280   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3710    2.0320   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.6820    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520   -0.7520    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4490    2.7380   -1.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0980    2.2570    0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7380    2.9370    0.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460    1.7760   -1.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8400   -1.2710    1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9820   -0.7670   -1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100   -0.8560    1.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6100    3.4600   -1.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    2.9810    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9630    3.5680    0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4680    2.4140   -1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0520   -1.9240    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930   -1.4250   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5180    3.5820   -0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8280    3.3050   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7290   -1.9990   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6610    4.2940   -0.8300 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3780    4.2360    0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6840    5.0230    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3790    6.4450    0.0670 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    6.9850    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6450    7.1000   -0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 19  2  0  0  0  0
 14 20  2  0  0  0  0
 15 20  1  0  0  0  0
 16 21  2  0  0  0  0
 17 21  1  0  0  0  0
 18 22  2  0  0  0  0
 19 22  1  0  0  0  0
 20 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 26 28  1  0  0  0  0
M  END
>  <ID>
tamoxifen

> <PRIMARY_SOM>
27 28

> <SECONDARY_SOM>
21

>  <Citation>
J. A. Styles et al., Carcinogenesis, 1994, 15, 5-9

$$$$
tegafur
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
    6.6960   -0.3830    0.8750 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -0.4070    2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1800   -4.3660    1.8820 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870   -2.9820    0.9680 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -2.0840    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3240   -3.6770    1.4260 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240   -1.6940    1.8100 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4360   -1.5700    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4310   -0.5020    0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530    0.4220    1.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9590   -3.4380    1.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5070   -1.0880    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7950   -1.3500    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3030   -2.7300    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  2  7  1  0  0  0  0
  2 10  1  0  0  0  0
  3 11  2  0  0  0  0
  4 14  2  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
tegafur

> <PRIMARY_SOM>
7

>  <Citation>
Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M.; Yokoi, T. Roles of Cytochromes P450 1A2 2A6, and 2C8 in 5-Fluorouracil Formation from Tegafur, an Anticancer Prodrug, in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 1457–1463. 

$$$$
theobromine
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -5.9060    0.0420   -1.1980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5800   -2.3050    0.9880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6740    1.5130   -2.6250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8900   -0.6890   -0.5560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2100   -1.1150   -0.1220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5200    1.0760   -2.2370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6470    0.5240   -1.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3170    0.2750   -1.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7090   -0.1610   -1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.4310    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3690    1.8120   -2.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4690   -0.9290   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8360    2.1400   -3.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0  0  0  0
  2 10  2  0  0  0  0
  3  7  1  0  0  0  0
  3 11  1  0  0  0  0
  3 13  1  0  0  0  0
  4  8  1  0  0  0  0
  4 10  1  0  0  0  0
  4 12  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6  8  1  0  0  0  0
  6 11  2  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
M  END
>  <ID>
theobromine

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
11 13

>  <Citation>
Gates, S.; Miners, J.O. Cytochrome P450 Isoform Selectivity in Human Hepatic Theobromine Metabolism. Br. J. Clin. Pharmacol. 1999, 47, 299–305.

>  <DOI>
10.1046/j.1365-2125.1999.00890.x

$$$$
theophylline
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.2130    0.5920    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370    1.3820    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0200    2.5990    0.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    0.6030   -0.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    1.3030   -0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340   -0.7960   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1870   -1.3920   -0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0870   -1.4650   -0.1920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1180   -2.8950   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.7620    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890   -1.2730    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420   -0.2170    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    0.9400    0.4830 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
theophylline

> <PRIMARY_SOM>
12

>  <Citation>
Zhang and Kaminsky,Biochem. Pharmacol.,50,205,1995

>  <DOI>
10.1016/0006-2952(95)00120-O

$$$$
thioridazine
  MOE2008           3D

 25 28  0  0  1  0  0  0  0  0999 V2000
   -0.9640    0.8750    0.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.4900    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -0.9560    1.9930 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2420    1.4560    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -1.4430    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    0.7390    1.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.7600    0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    3.5460   -2.7700 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1700   -0.9020   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.2420   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120    3.1940   -1.3480 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5680   -2.7940    0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -2.2540   -0.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -2.7690   -1.8460 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5840   -3.2010   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4880    2.3410   -3.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    4.4280   -3.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    2.7920    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.3590    1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930    4.4630   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.5780   -1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3800    5.7340   -2.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560    3.4020    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200    2.6890    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650    5.4220   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  7  1  0  0  0  0
  2  5  2  0  0  0  0
  2  9  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  6  2  0  0  0  0
  4 18  1  0  0  0  0
  5 12  1  0  0  0  0
  6 19  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  8 16  1  0  0  0  0
  8 17  1  0  0  0  0
  9 13  2  0  0  0  0
 10 11  1  0  0  0  0
 11 20  1  0  0  0  0
 12 15  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 21  1  0  0  0  0
 17 22  1  0  0  0  0
 18 23  2  0  0  0  0
 19 24  2  0  0  0  0
 20 25  1  0  0  0  0
 22 25  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
thioridazine

> <PRIMARY_SOM>
3

>  <Citation>
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

>  <DOI>
10.1124/dmd.105.006445

$$$$
toluene
  MOE2008           3D

  7  7  0  0  0  0  0  0  0  0999 V2000
    1.2070    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.3980   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8860   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.3880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
toluene

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
6

>  <Citation>
Tamie Nakajima , Rui-Sheng Wang, Eivor Elovaara, Frank J. Gonzalez, Harry V. Gelboin, Hannu Raunio, Olavi Pelkonen, Harri Vainio and Toshifumi Aoyama. Toluene Metabolism by cDNA-Expressed Human Hepatic Cytochrome P450, Biochemical Pharmacology, Vol. 53, pp. 271-277, 1997

>  <DOI>
10.1016/S0006-2952(96)00652-1 

$$$$
trichloroethane
  MOE2008           3D

  5  4  0  0  0  0  0  0  0  0999 V2000
    1.7110    4.8270    1.5520 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.3180    3.9800    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7080    4.8320   -1.4010 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.1160    3.9890    0.0780 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.7980    2.5440    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
M  END
>  <ID>
trichloroethane

> <PRIMARY_SOM>
5

>  <Citation>
Guengerich et al., Chem. Res. Toxicol., 1991, 4, 168-179

$$$$
trimethadione
  MOE2008           3D

 10 10  0  0  0  0  0  0  0  0999 V2000
    1.1480    0.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2940   -0.9220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1740    1.4180   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9830   -0.4900    0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440    0.8520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0810    1.4830   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1540   -1.3710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790   -2.0720   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0170    0.3880    1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0190    0.3870   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  9  1  0  0  0  0
  1 10  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  4  7  1  0  0  0  0
  5  6  2  0  0  0  0
M  END
>  <ID>
trimethadione

> <PRIMARY_SOM>
7

>  <Citation>
N. Kurata et al., Xenobiotica, 1998, 28, 1041-1047

$$$$
troglitazone
  MOE2008           3D

 31 34  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3770    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970    2.1490    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    2.0410    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.7840    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1860   -0.7170   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1960    1.4460    0.5620 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.4270    1.3320    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2800    3.5470    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4540    0.1810   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4020   -0.0550   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -2.2240   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4400    2.3370    0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8750    1.0570    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7440    2.0630    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5650   -0.7590   -0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2380    3.4620    1.3920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3690    4.2130    1.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680    5.3850    2.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4280    3.8060    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6180    6.1460    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5770    4.5710    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6710    5.7420    1.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250    6.5740    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9050    6.1150    2.2080 C   0  0  3  0  0  0  0  0  0  0  0  0
   10.2350    6.8460    2.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3740    6.6800    3.8740 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.5620    7.5900    3.1390 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9460    6.7510    1.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7890    7.7100    4.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0040    8.3660    5.2350 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  6 12  1  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  8 15  1  0  0  0  0
 11 16  1  0  0  0  0
 13 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  2  0  0  0  0
 21 23  2  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  1  0  0  0  0
 26 28  1  0  0  0  0
 26 29  2  0  0  0  0
 27 30  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
M  END
>  <ID>
troglitazone

> <PRIMARY_SOM>
16

> <SECONDARY_SOM>
25 27

>  <Citation>
Yamazaki et al., Drug Metab. Dispos.,27,1260,1999; He et al., Drug Metab. Dispos., 2004, 32, 442-446; He et al., Drug Metab. Dispos., 2004, 32, 639-646

$$$$
urporphyrinogen
  MOE2008           2D

 60 64  0  0  0  0  0  0  0  0999 V2000
   13.6810   -0.5980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5900   -4.6900    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3220    6.1980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720    2.0080    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0040    0.9970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2380   -4.1590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7510    5.4690    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2410    0.4100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5010    4.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0080   -5.6980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4170    5.0440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540   -2.8180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5500    3.0340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4030   -4.6710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8120    6.0710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4880   -1.3180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6260    0.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1240   -0.6870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0910    2.0520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6210    0.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1940    1.4850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9260   -1.2880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2890    2.6870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0540   -0.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2270   -0.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3230   -1.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9260    2.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0540    1.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8940    2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280   -1.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3210    2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3550   -1.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1630    1.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6250   -2.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5900    3.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860    0.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1630    0.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6240   -2.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5920    3.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860    1.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9590    1.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2180   -3.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9980    4.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   -0.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9620   -0.3860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9530   -2.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1670    4.4720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2900    1.7890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8320    2.8150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8170   -3.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0040    4.3490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   -1.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8820    0.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2600   -3.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7470    5.3800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680    1.4020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6280    3.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4100   -4.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4110    5.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540   -1.8180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 53  1  0  0  0  0
  2 54  1  0  0  0  0
  3 55  1  0  0  0  0
  4 56  1  0  0  0  0
  5 53  2  0  0  0  0
  6 54  2  0  0  0  0
  7 55  2  0  0  0  0
  8 56  2  0  0  0  0
  9 57  1  0  0  0  0
 10 58  1  0  0  0  0
 11 59  1  0  0  0  0
 12 60  1  0  0  0  0
 13 57  2  0  0  0  0
 14 58  2  0  0  0  0
 15 59  2  0  0  0  0
 16 60  2  0  0  0  0
 17 21  1  0  0  0  0
 17 25  1  0  0  0  0
 18 22  1  0  0  0  0
 18 26  1  0  0  0  0
 19 23  1  0  0  0  0
 19 27  1  0  0  0  0
 20 24  1  0  0  0  0
 20 28  1  0  0  0  0
 21 29  1  0  0  0  0
 21 33  2  0  0  0  0
 22 30  1  0  0  0  0
 22 34  2  0  0  0  0
 23 31  1  0  0  0  0
 23 35  2  0  0  0  0
 24 32  1  0  0  0  0
 24 36  2  0  0  0  0
 25 30  1  0  0  0  0
 25 37  2  0  0  0  0
 26 32  1  0  0  0  0
 26 38  2  0  0  0  0
 27 29  1  0  0  0  0
 27 39  2  0  0  0  0
 28 31  1  0  0  0  0
 28 40  2  0  0  0  0
 33 37  1  0  0  0  0
 33 41  1  0  0  0  0
 34 38  1  0  0  0  0
 34 42  1  0  0  0  0
 35 39  1  0  0  0  0
 35 43  1  0  0  0  0
 36 40  1  0  0  0  0
 36 44  1  0  0  0  0
 37 45  1  0  0  0  0
 38 46  1  0  0  0  0
 39 47  1  0  0  0  0
 40 48  1  0  0  0  0
 41 49  1  0  0  0  0
 42 50  1  0  0  0  0
 43 51  1  0  0  0  0
 44 52  1  0  0  0  0
 45 53  1  0  0  0  0
 46 54  1  0  0  0  0
 47 55  1  0  0  0  0
 48 56  1  0  0  0  0
 49 57  1  0  0  0  0
 50 58  1  0  0  0  0
 51 59  1  0  0  0  0
 52 60  1  0  0  0  0
M  END
>  <ID>
urporphyrinogen

> <PRIMARY_SOM>
29 30 31 32

>  <Citation>
Sinclair et al., Drug Metab. Dispos., 1998, 26, 1019-1025

$$$$
verapamil
  MOE2008           3D

 33 34  0  0  1  0  0  0  0  0999 V2000
   -6.8870    1.3830    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5490    1.1060   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0780    0.1010   -1.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9480   -0.6180   -0.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9600    2.9830    0.5170 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7220    1.9370   -1.3240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7250   -0.1740   -2.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6590    1.8150   -0.5170 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -1.1800    1.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4200   -2.5320   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6420   -3.5010    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8340   -2.5570   -1.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5010   -1.0980    2.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7680    1.7300    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6580    1.2010   -0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4580   -0.0770   -1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3760   -0.8230   -0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4920   -0.2980   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6890    0.9740    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140   -1.1160    0.4120 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.0180   -0.4660   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8190   -1.2140    0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4700   -0.4690    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6210   -1.1880    0.7210 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.8190   -0.4240    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0620   -1.1210    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2910   -0.3370    0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7560    0.6650    1.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8990    3.2320    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4370    1.1310   -2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0080   -1.2390   -2.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8860    2.7590    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3030   -1.2290    3.0170 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 28  2  0  0  0  0
  2  3  2  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4 27  2  0  0  0  0
  5 14  1  0  0  0  0
  5 29  1  0  0  0  0
  6 15  1  0  0  0  0
  6 30  1  0  0  0  0
  7 31  1  0  0  0  0
  8 32  1  0  0  0  0
  9 20  1  0  0  0  0
  9 33  3  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 20  1  0  0  0  0
 13 24  1  0  0  0  0
 14 15  1  0  0  0  0
 14 19  2  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
verapamil

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
25

> <TERTIARY_SOM>
32

>  <Citation>
Tracy et al.,Br. J. Clin. Pharma.,47,545,1999

>  <DOI>
10.1046/j.136502125.1999.00923.x.

$$$$
zileuton
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
   -0.0240    1.6300    0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    0.1680    0.1310 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.0030    2.4640    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    2.6620    0.7340 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280   -0.5500    0.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2000    0.0110   -1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7330    3.8520    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    4.1860    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.2120    0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6850   -1.6000    1.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6530    4.8930    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    5.4580    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2740   -0.7700    1.4550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6270    0.5960   -0.1730 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    6.1430    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380    6.4450    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  7  8  2  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
  9 14  2  0  0  0  0
 11 15  2  0  0  0  0
 12 16  2  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
zileuton

> <PRIMARY_SOM>
11 12 15 16

>  <Citation>
J. M. Machinist, M. D. Mayer, M. S. Shet, J. L. Ferrero, A. D. Rodrigues, Drug Metab. Dispos. 1995, 23, 1163-1174.

$$$$
zotepine
  MOE2008           3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.3360    1.9550   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    0.5680   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.8440   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350    2.5460   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420   -0.3530   -0.6610 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550   -0.1860   -0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6110    2.8100   -0.9440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3280    3.8820    0.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    1.7860   -0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    0.5030   -1.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.4160   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0330    1.8850   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    3.3140    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.5460   -0.4110 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -0.2880   -3.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7900    2.4390   -3.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350    4.2160    3.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0410    0.2780   -4.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2850    1.6450   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    4.1450    2.9580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    2.8340    3.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230    5.1130    3.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 10 12  2  0  0  0  0
 10 15  1  0  0  0  0
 12 16  1  0  0  0  0
 13 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 17 20  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
zotepine

> <PRIMARY_SOM>
22 21

>  <Citation>
Shigura et al.,Xenobiotica,29,217,1999

>  <DOI>
10.1080/004982599238623

$$$$
